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1. SUMMARY 
Embolization for the treatment of Cranial Dural Arteriovenous Fistulae 
(CDAVF) was developed as an alternative to open surgical approach and 
soon appeared as a more attractive treatment mainly due to less 
invasiveness.  
Nevertheless, still many aspects regarding etio-pathogenesis, 
pathophysiology, natural history as well as treatment strategies, effectiveness 
of endovascular approach, acceptable rate of complications and embolic 
materials, need exploration, better understanding and answers based on real 
evidence. 
Trying to contribute mainly in the aspects related to the treatment, we 
studied retrospectively a consecutive series of 154 adult patients treated 
endovascularly during last 15 years. Sixty-seven were women and 90 men 
with age ranged from 22 to 82 years (mean 57 y). The interval from 
presentation to treatment was recorded in 61 patients and ranged from 1 
week to 10 years (mean 16.2 m). Potentially predisposing factors were 
identified in 11% of patients. One third of the patients were presented with 
aggressive symptoms. Ten patients had multiple shunts (6.3%). Twenty-five 
of the lesions were particularly extensive and complex, whereas the rest were 
located in various sites with the transverse and/sigmoid sinuses being the 
most frequent location (35%) followed by the cavernous plexus (25%) and 
the tentorium cerebelli (7.5%). 
Regarding classification according to the venous drainage, 74 cases were 
Borden (B) grade 1, 32 cases Borden grade 2 and 51 cases grade 3. 
Regarding location according to the epidural space 52 patients were 
associated with the Ventral Epidural (VE) space (33%), 45 patients with the 
Dorsal Epidural (DE) space (29%), 38 patients with the Lateral Epidural (LE) 
space (24%), 17 patients with both VE and DE spaces (11%) and 5 patients 
with both DE and LE spaces (3%). 
Almost all (97.3%) B1 lesions had a benigh presentation with the 25% of 
them having a venous outlet abnormality (VOA – thrombosis, stenosis, varix). 
Fifty per cent of those with aggressive presentation had a VOA. Two thirds of 
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the B2 lesion had benigh presentation with 52% having a VOA, whereas 72% 
of the rest with an aggressive presentation had a VOA. The vast majority 
(80.4%) of the B3 lesions had an aggressive presentation with half of them 
having a VOA. 
Most of the VE lesions had a benigh presentation (94.3%). Similarly 62.3% of 
the DE had a benigh presentation. In contrary 86% of the LE lesions had an 
aggressive presentation.  All lesions (100%) of the LE group had cortical 
venous drainage and showed a male predominance. 
A total of 189 operations were performed in 154 patients (average 1.2). The 
transarterial approach was applied in 85% of the operations, the transvenous 
approach in 9% and both approaches in 6% of the operations. NBCA (glue) 
was used as the only or main material in 65% of cases. 
The early angiographic results consisted of 68% complete occlusion, 20.5% 
subtotal occlusion, 8.5% extensive occlusion and 3% partial occlusion. 
Concerning early clinical outcome, disappearance of symptoms was 
observed in 24% of the patients, improvement in 11.7%, no new symptoms 
in 59%, temporary new symptoms in 2.6% and permanent new morbidity in 
2.6% of the patients due to operative complications.  
One hundrend and fifty-one patients were followed-up with MR imaging and 
clinical examination (range 1m to 15 years) for a mean of 2.9 years. Complete 
occusion was obtained in 87% of the patients. Three patients were lost to 
follow-up. According to the venous drainage pattern: 86% of the benign 
group and 88% of the aggressive group showed complete occlusion. 
Clinically 96% of patients had a good outcome (no 
symptoms/improvement/no new symptoms in case of aggressive 
presentation with neurological deficit). 
Two cases underwent additional surgery and no case had additional 
radiosurgery. 
The above-described management with its particular aspects described in 
the main body of the study yielded results characterized by high success and 
low complication rates. These results justify the use of endovascular 
operation as the treatment of choice for CDAVFs. 
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2. INTRODUCTION and HISTORICAL PERSPECTIVE 
 
Yasargil noted that Rizzoli, in 1873, described an arteriovenous malformation 
supplied by the occipital artery with drainage to the transverse sinus that 
involved the dura matter. (287) 
Cranial dural arteriovenous fistulas as a distinct entity were first described in 
the early 30’s by Sachs and subsequently by Tonnis.(1,2) However the 
description of spontaneous DAVF as distinct from traumatic direct shunt 
came much later in the early 50’s by Verbiest and Fincher. (3,4) 
In the early 60’s van de Werf reported the first case of a congenital high flow 
dural arteriovenous shunts in a child.(5) 
During that decade several groups reported on the topography of these 
lesions describing those in the cavernous sinus,(6) sigmoid and transverse 
sinuses,(7,8) and anterior cranial fossa.(9) 
At that time intracranial hemorrhage as presenting manifestation of a dural 
shunt was attributed to some pial compartment of the lesion.(7,9,10) 
In the late 1960’s groups from both Europe and US started to explore 
systematically dural arteriovenous shunts, with external carotid catheter 
angiography (11-14) and generally the diagnosis of dural arteriovenous (AV) 
shunts presented significant advancement.(15,16) 
 In the mid-1970s the group of Lariboisiere establish the first 
angioarchitectural classification of dural arteriovenous shunts (17,18) 
Although a topographical and angioarchitectural classification was 
introduced, no clear distinction between anatomical factors predisposing to a 
benign or aggressive clinical presentation was still apparent. (15,19,20)  
The assumption that clinical symptoms could be related to the venous 
drainage patterns appeared in 1972, when Houser et al (16) in their publication 
correlated angiographic features with clinical symptoms and concluded that 
intracranial hemorrhage occurred when venous drainage was directed to the 
pial veins. 
Subsequently, Kosnick et al (21) observed that dural AV shunts, could induce 
neurologic symptoms due to characteristics related to their 
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angioarchitecture.  
These publications led to a better understanding of vascular anatomy and 
behaviour of these lesions. Later DAVFs draining into the cortical veins were 
categorized as a separate entity (22) and were described more in detail and 
classified correlating their patterns of venous drainage with clinical 
presentation in 1978 by Djindjian et al. (18) They proposed that cortical venous 
drainage might produce aggressive neurologic symptoms and hemorrhage.  
During the 1980’s, many authors reported the particular risk for hemorrhage 
from dural AVFs located at the floor of the anterior cranial fossa and at the 
tentorium cerebelli. (23-26) Gradually also more evidence for the acquired 
nature of these lesions appeared. (27) 
During that period more authors published also on the role of cortical venous 
drainage in dural shunts and its correlation with neurological manifestation 
and natural history of the disease. (51) 
In 1984, Malik et al (25) in their review of 223 previously reported cases 
although concluded that lesions related to large dural sinuses are less likely 
to bleed than lesions with restricted dural outflow, they failed to notice the 
role of the pattern of venous drainage.  
In 1986, Lasjaunias et al (28) presented a meta-analysis of 191 cases and 
made a step further by analyzing the mechanism of neurologic 
manifestations and concluding that central nervous system symptoms seem 
to be related to passive venous hypertension. Furthermore detailed 
descriptions of the vascularization of the cranial dura by Lasjaunias helped to 
further understand the potential for endovascular approach to DAVS and the 
associated risks (29,30) 
In 1990, Awad et al (31) reviewed 360 cases reported in the literature and 17 of 
their own cases and compared the angiographic features of 100 aggressive 
cases with 277 benign cases. They concluded that cortical venous drainage 
(CVD), variceal or aneurysmal venous dilatations, and galenic drainage were 
features heralding aggressive neurologic signs.  
Early approaches to treatment consisted of surgical ligation of the ECA, 
resection of the fistula in the region of the cavernous sinus, and transarterial 
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embolization of ECA feeders with particles. For fistulas of the transverse and 
sigmoid sinuses, surgery had become the main way of treatment by the mid 
1980s. (32) Later some new surgical (33) or endovascular therapeutic techniques 
have been described. In 1984, Viñuela et al and Lasjaunias P et al reported 
their series of patients with spontaneous dural arteriovenous shunts treated 
with transarterial embolization with polyvinyl alcohol (PVA) particles or 
isobutyl cyanoacrylate (IBCA). (34,30) 
In 1987, Halbach et al (35) reported the results of transarterial embolization in 
patients with dural fistulas of the transverse and sigmoid sinuses. In 1986 the 
same group began using a transvenous route of embolization in selected 
patients and in 1989 they published a couple of reports on the transvenous 
embolization of dural fistulas as the option of first resort in endovascular 
treatment of cavernous dural fistulas and elsewhere when applicable. (36) 
Recently Davies and van Dijk identified morphological subgroups with 
different natural histories, facilitating patient selection and helping establish 
therapeutic goals in each subgroup. (37-39) 
One of the last contributions of P. Lasjaunias, which added a lot to our 
understanding of this disease, was his study on comparative venous 
anatomy at the level of the spine and skull and the introduction of a new 
classification system of cranial dural arteriovenous fistulae based on the 
craniospinal epidural venous characteristics. (40)  
3. EMBRYOLOGY and VASCULAR ANATOMY of the CRANIAL DURA 
Matter 
 
The brain and spinal cord of animals are covered by one or more layers of 
connective tissue, which are called the meninges, from the Greek word 
meninx, which means membrane. In fishes, only a single layer is present. 
Amphibians and reptiles have two meningeal layers. In mammals and birds, 
three meningeal layers are present. The outermost layer is the dura mater 
(means „hard mother“) and is actually composed of two layers: an inner layer 
enclosing the central nervous system and an outer layer that lines the inside 
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of the skull. The use of the word “mother”to describe these membranes 
comes from an ancient notion that they were the origin, or mother, of all 
membranes in the body. (41) 
 
The cranial meninges originate from several sources such as the prechordal 
plate, the parachordal mesoderm and the neural crest. At 5 weeks of 
development the loose mesenchyme around the brain forms the primary 
meninx. At 7 weeks, the cranial pachymeninx and leptomeninx are 
distinguishable. (42) 
The dura matter covering the convexity of the cranial vault (membranous 
bone) has a different origin than the dura covering the skullbase 
(cartilagenous bone). As a result of this difference, different relatioships and 
interactions between bone, dura and venous system should be expected. 
Dural sinuses are large venous collectors located between two layers of the 
dura matter. Septations often occur within the sinuses and result in separate 
venous channels adjacent to each other.  
There are no dural sinuses in the midline of the skullbase or at the spinal cord 
level. In these locations only venous plexiform channels in the epidural space 
are present. These are the cavernous plexus (the so-called sinus), the clival 
plexus and the plexus along the anterior aspect of the foramen magnum in 
continuation with the ventral spinal venous plexus. 
Other structures tightly related to the dura are the transdural segments of the 
cerebral veins just proximal to their estuary to a sinus. They are found near 
the superior saggital sinus (SSS) the transverse sinus close to the tentorium, 
the middle cranial fossa and lamina cribriformis. CDAVFs often affect this 
part of the dural system. 
 
The venous sinuses change with age. Few months after birth the cavernous 
plexus (primarily not part of the cerebral venous system) „captures“ the 
sylvian vein offering to the brain an alternative venous drainage, whereas the 
jugular bulb continues to mature after birth and after the regression of the 
occipital and marginal sinuses. (43) 
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Electron microscopy studies have shown that there is a continuous layer of 
cells between the inner table of the bone and the subarachnoid space. The 
outermost (periosteal) dural side is attached to the skull by extensive 
amounts of intertwining extracellular collagen. This attachment is particularly 
strong at the cranial base and the sutures. Contained within this layer are 
fibroblasts, osteoblasts, nerve fibers, and dural vessels. In contrast, the inner 
(meningeal or juxta-arachnoid) dural side has proportionately more 
fibroblasts and less collagen. It separates from the periosteal dura to form 
the walls of the larger sinuses. Immediately below the meningeal aspect of 
the dura is an easily disrupted dural barrier cell layer, which, compared with 
the other dural layers, contains little collagen.  
 
Regarding the dural microvasculature there are two important works who 
focused on the morphology and microstructure of the intrinsic dural vessels 
by Kerber and Roland (44,45) 
There are three sets of sub-branches that arise throughout the course of all 
main meningeal arteries. These numerous primary anastomotic arteries (100–
300 μm in diameter) are interconnected with one another and with short 
secondary anastomotic arteries (20–40 μm in diameter). Another set of sub-
branches the penetrating arterioles (5-15 μm) contributes to an extremely rich 
capillary network on the inner (juxtaarachnoid) side of the meningeal dura. 
The last set of arteries arises throughout the course of the main meningeal 
branches to directly supply the adjacent skull. It should also be noted that a 
random network or plexus of venous lakes and crevices is found within all of 
the dura. Kerber and Newton reported also the existence of probably plentiful 
arteriovenous shunts in the midportion of the dura. No later publications have 
reported on similar finding. 
 
Vessels of the cranial vault dura  
Some of the dura lining the skull vault may be supplied by the transosseous 
branches of two scalp arteries: the occipital and posterior auricular; however, 
most of it is supplied by the middle meningeal artery. The middle meningeal 
  11 
artery divides into four main branches from frontal to temporo-ocipital. These 
branches are 400–800 μm in diameter. A dural vein is often larger than the 
adjacent artery, and frequently, the veins almost encircle the artery, creating 
what has been called a meningeal sinus. This structure can connect the 
superior sagittal sinus with the sphenoparietal sinus. Most of the convexity 
meningeal vein-pairs enter the superior sagittal or transverse sinuses. Some 
form a plexus 1–2 cm in width, the lateral lacunae, can be found along the 
lateral aspects of the superior sagittal sinus. This plexus receives emissary 
veins from the scalp, diploic veins from the skull, and occasionally cerebral 
veins. (47)  
 
Vessels of the skull base dura 
Three main arteries supply the dura of the skull base. The internal carotid, 
vertebral, and external carotid arteries. Their vascular territories are variable. 
The internal carotid artery supplies the sellar and parasellar region via the 
meningohypophyseal and inferolateral trunks. The ophthalmic artery gives 
rise to the ethmoidal branches that supply the cribriform region and the 
anterior frontal meningeal branch that supplies the anterior fossa. The 
vertebral artery contributes to the dura of the posterior fossa via two 
branches directly, the posterior (often coming from the PICA) and anterior 
meningeal, and one branch indirectly, the subarcuate branch arising from the 
AICA. Three external carotid artery branches contribute  to the supply of the 
skull base dura. The ascending pharyngeal artery supplies the dura around 
and in the jugular foramen and contributes to the clival, odontoid arch plexus, 
and cerebellar pontine plexus. The maxillary artery gives rise to the middle 
meningeal, which supplies the middle and anterior cranial fossa. The occipital 
artery supplies a variable region of the dura in the posterior fossa via the 
mastoid and other meningeal branches.  
 
Vessels  of the falx cerebri and cerebelli 
The vasculature in the falx cerebelli, falx cerebri, and tentorium lies within the 
two layers of the dura. 
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Along the attachment of the falx cerebri to the convexity, the anterior and 
posterior paramedian arteries form a prominent arcade. These arteries 
interconnect at the midline across the superior sagittal sinus and are 
particularly large when one middle meningeal artery is hypoplastic. The 
sinuses do not constitute an arterial barrier, so both meningeal arteries can 
cross the midline. The inferior margin of the falx cerebri is supplied by the 
anterior and posterior cerebral arteries. The ophthalmic artery supplies 
ethmoidal (anterior meningeal) branches to the crista falciformis, the anterior 
attachment of the falx cerebri in the cribriform region. The vertebral artery 
supplies the posterior meningeal artery and its terminal branches to the falx 
cerebelli and part of the falx cerebri. The maxillary artery contributes through 
the middle meningeal to the supply of superior falx cerebri.  
The meningeal veins that drain the falx cerebelli and cerebri are inconsistent 
and unnamed, but they enter the adjacent sinuses. The most consistent 
features are the presence of a large vein connecting the superior sagittal 
sinus to the proximal inferior sagittal sinus in 10% of specimens and a large 
venous lake at the dorsal portion of the inferior sagittal sinus in 30% of 
specimens (47) 
 
Vessels of the tentorium 
The multiple patterns of vascular supply to the tentorium are complicated 
because the lower and upper surfaces are supplied by different arteries. 
Regarding the inferior surface the supply is coming from the basilar, superior 
cerebellar, occipital, and posterior meningeal branch from the vertebral 
arteries.  
For the upper tentorial surface there is supply from six branches. The 
posterior cerebral may supply through the so-called Schechter-Davidoff 
branch. The internal carotid artery contributes supply via the marginal (called 
also Bernasconi-Cassinari) and basal tentorial branches. The vertebral artery 
may supply the posterior meningeal branch. Three external carotid artery 
branches contribute vessels to the tentorium dura. The ascending 
pharyngeal, the middle meningeal artery and the occipital artery. (48-51)  
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The complexity of the vascular supply of the dura requires that any 
angiographic assessment of dural lesions requires visualization of the 
circulation of both vertebral, both internal carotid, and both external carotid 
arteries for most of the locations.  
4. ETIOPATHOGENESIS and PATHOPHYSIOLOGY of CDAVFs 
 
Most of the authors agree on the acquired nature of these lesions. (15, 18, 27, 31, 32, 
44, 52-66) in the adult population. Moreover, laboratory studies have 
demonstrated that sinus thrombosis (53, 62, 65, 67-73) combined with venous 
hypertension (52, 63, 66, 74-85)  reliably produces CDAVFs. This in turn leads to 
tissue hypoxia and activation of angiogenesis, (80,86,87) through various 
angiogenic factors (88) leading to eventual formation of DAVFs. 
Hypercoagulable states predispose patients to venous sinus thrombosis and 
can occur after acquired conditions such as trauma or infection and in 
pregnancy or during oral contraceptive therapy or in genetic conditions that 
result in thrombophilia as factor V Leiden mutation, prothrombin G20210A 
mutation, and protein C and protein S deficiencies.(79, 83, 84, 89-102) 
The exact mechanisms triggering the formation and progression of 
arteriovenous dural shunts in patients with preexisting sinus thrombosis is 
unknown. Seems that sinus thrombosis is a precipitating factor in the 
pathogenesis of DAVF only if it has induced venous hypertension. (103) 
DAVF formation is more likely to be associated with venous hypertension 
than with sinus thrombosis as Chen et al reported recently. Based on their 
experiments they proposed that venous hypertension might induce chronic 
regional hypoperfusion and vascular endothelial growth factor (VEGF) 
expression. Angiogenesis in response to venous hypertension, 
hypoperfusion, and angiogenic factors could promote collateral venous 
drainage, which serves to reverse the venous hypertension and 
hypoperfusion. However, if the chronic congestion of the venous outflow 
leads to prolonged secretion of VEGF, MMPs (matrix metalloproteinases), 
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and other humoral factors, which stimulate vascular endothelial proliferation 
and excessive angiogenesis in the dura mater around the sinus, the 
meningeal capillaries may connect to dural sinuses, or connection of the 
arteries and veins in the dura mater occurs to initiate arteriovenous shunting. 
(104)  
Neonatal cases (5, 105-109) indicate a congenital origin and a different variety for 
the children population.  
However reports refering to links between specific genes and sporadic 
arteriovenous fistulas have been also appeared (110) 
As a comprehensive summary seems that several known but mainly 
unknown causes can induce angiogenesis which will connect the osteodural 
arteries with the sinuses, regional dural veins and/or cortical veins depending 
among other factors on the location of the lesion. Changes in the venous 
structure promoting thrombosis can occur before, during or after the 
angiogenic proccess. The resulting lesion will be manifested with various 
symptoms depending on the interaction of several interassociated factors, 
the location, the extent and hemodynamics of the shunt, the collateral 
venous circulation and the time –rate of progression being some of the 
apparent ones.(111,112)  
5. EPIDEMIOLOGY and NATURAL HISTORY of CDAVFs 
 
In relation with other vascular pathologies we know that CDAVFs account for 
10% to 15% of all intracranial arteriovenous malformations  (13) 
Recently, an epidemiological survey of the detected brain vascular 
malformations  was conducted with detection rates per 100 000 person-
years  2.0 (95% CI, 1.8 to 2.3) for dural fistulas, cavernous malformations, 
Vein of Galen malformations, and venous malformations (113) 
 
Another study  including only DAVF cases in Japan yielded a detection rate 
of 0.29 DAVF cases per 100,000 adults per year. Furthermore, unlike Europe 
and North America where cases of transverse-sigmoid sinus DAVF are 
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predominantly detected, in Japan, a higher number of cases of cavernous 
sinus lesions are detected, indicating racial difference in the presentation of 
DAVF. (114) 
A previous survey from Scottland reported a crude detection rate (per 
100,000 adults per year) of 0.16 (95% CI, 0.08 to 0.27) for dural AVMs (115) 
Recently and departing from different point of view Geibprasert et al 
presented the results of a multiethnic study on the potential differences in 
demographic, angiographic and clinical characteristics of different types of 
DAVFS in Europe, South America, and Asia trying to find out whether the 
same clinical profile for lesions located in the ventral (VE), dorsal (DE) or 
lateral (LE) epidural spaces, is present in different ethnicities. Interestingly 
they reported that DE-shunts in the Asian population were more aggressive 
secondary to a higher rate of venous outlet alteration (VOA) with associated 
CVR. (116)  
 
The natural history of CDAVFs or otherwise their clinical course once 
identified, has been addressed last years by several publications.  
From previous sporadic reports we know that CDAVFs can present 
spontaneous regression.  At least 15 cases have been presented in the 
literature (27, 117-126) whereas in a recent study aiming to define the incidence 
and clinical characteristics of patients with DAVFs showing spontaneous 
angiographic pattern conversion a percentage of 12.5% of spontaneous 
occlusion of the shunt was reported. (127) 
Luciani et al proposed that two types of spontaneously regressing dural AVFs 
must be distinguished: posttraumatic and spontaneous. The mechanisms 
accounting for all dural AVF regressions remain unclear. A direct occlusion of 
the intradural shunts, rather than dural sinus thrombosis, could be 
responsible for this process in some cases. (117) 
 
Cranial dural arteriovenous fistulas (DAVFs) can be classified into benign or 
aggressive, based on their patterns of venous drainage. Benign lesions do 
not have cortical venous drainage and are presented with benign symptoms 
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non directly related to the CNS, as tinnitus, venous congestion in the orbita 
with or without cranial nerve deficit, headache etc. Nevertheless it is not clear 
whether this initially benign appearance persists over time. Satomi et al (128) 
studied the clinical course of 117 consecutive patients with benigh lesions 
(with palliative treatment of 44 of them) and found in a median follow-up 
period of 27.9 months that 98% of this population preserved a „benign“ level 
of disease whereas in two cases (2%) managed conservatively CVD 
developed. In both of these cases the conversion from benign to aggressive 
DAVF was associated with spontaneous progressive thrombosis of venous 
outlets.  
From the same group of Toronto University and with an expanded patient 
cohort a recent publication (127) reported that studing the evolution of patients 
with benigh lesions found that spontaneous angiographic conversion 
(defined as complete occlusion of a pre-existing DAVS or conversion of a 
benign into an aggressive lesion on follow-up DSA) without any treatment, 
was 12.5% for spontaneous occlusion of the shunt and 4% for conversion to 
an aggressive lesion from benign DAVF , concluding that DAVFs are dynamic 
disorders, which will show chronological progression.  
Furthermore, seems that the natural history of aggressive CDAVFs is even 
more complex. Previous and recent studies on the events later than the initial 
presentation were performed by Duffau et al.,(132) Brown et al., (68) Davies et 
al., van Dijk et al.,  (37, 38) Soderman et al., (133) Strom et al., (134) and Bulters et 
al.(135)  
The Duffau et al study focused on a short period of 20 days post-
presentation event. Brown et al followed patients for a longer time (mean of 
6.6 years) however, they did not studied separetely the patients with CVR. 
The van Dijk study examined an expanded patient cohort initially published in 
1997 by Davies 
et al. and they calculated for a group of 20 patients an annual mortality rate 
of 10.4%, an annual risk for hemorrhage or nonhemorrhagic neurological 
deficit during follow-up 8.1% (4.5 times the annual rate of 1.8% reported by 
Brown et al) and 6.9%, respectively, resulting in an annual event rate of 
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15.0% 
Almost simultaneously another study from the swedish group published a 
similar study based on the records of  85 patients with dural arteriovenous 
shunts with CVD. They found, for those patinets who presented with 
hemorrhage an annual risk for hemorrhage of 7.4% and in those not 
presenting with a hemorrhage a risk of 1.5%. They concluded that the natural 
course of DAVFs with CVD is  most probably more benign than previously 
proposed, in particular for patients with a presenting event other than an 
intracranial hemorrhage. 
More recently one more study by Strom et al. pointed out that the previous 
studies on the CDAVFs with CVD included patients the great majority (80-
100%) of whom had an aggressive manifestation whereas several such 
lesions including 17 of the 28 DAVFs in their series, are discovered 
incidentally or present with benign symptoms. By studying separetely these 
two groups of different actual presentation they found an apparent less 
aggressive clinical course (1.4% annual event rate) for the lesions with 
benign manifestation and a very high risk of new ICH or non-hemorrhagic 
neurological deficit (19.0% per year) fort he group of lesions that have been 
already presented aggressively. Interestingly, they noticed that although they 
share venous drainage with the cortical circulation, lesions with CVD and 
benign manifestation may lack or have less severe cortical venous 
hypertension. This may be attributable to less flow through the fistula, more 
efficient collateral pathways to uninvolved dural sinuses, or other factors at a 
microvascular level.  
Lately Bulters et al. trying to explain differences between these studies and 
to help estimate the risk of specific fistulae curried out a study of 70 patients 
harbouring 75 CDAVFs with CVD and found in 90.1 years of follow up a 
crude annual risk of hemorrhage of 8.9%. Untreated lesions had a risk of 
12.7%. Partial treatment reduced the risk of haemorrhage to 4.7%. The 
presence of a varix increased the risk of haemorrhage seven fold (3.5% 
versus 26.6%). Patients presenting with a haemorrhage (20.4%) or non-
haemorrhagic neurological deficit (22.2%) had a higher risk of haemorrhage 
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than those with a benign presentation (4.3%). 
Although the information presented above should not affect the management 
of DAVF patients who are considered at high risk at the present time, it does 
prompt discussion about the need for aggressive treatment for all DAVF 
patients with CVD and the potential further heterogeneity of the group. (136,137) 
 
6. CLASSIFICATIONS  
 
Djindjian and colleagues (18) proposed the first comprehensive classification 
of intracranial dural AVFs based on radiological anatomy in 1977; this 
classification used location as the main identity of the lesion. This scheme 
has subsequently been modified by Cognard et al. (130) In their series of 205 
patients they were able to show a relationship between type and aggressive 
presentation. Later a similar, but simplified, version of this classification was 
proposed by Borden, et al.(62) They proposed their classification as a 
predicting tool for lesion behavior and how it might serve as a rationale for 
treatment (129) (Table 1). 
Recently a publication by Geibprasert et al proposed a new classification of 
the CDAVFs.(40) According to the concept presented the craniospinal epidural 
spaces can be categorized into 3 different compartments related to their 
specific drainage role of the bone and central nervous system. CDAVFs 
developed in different epidural compartments constitute groups of lesions 
with different venous drainage pattern, the ventral epidural, dorsal epidural, 
and lateral epidural groups.  
Three main observations of the venous development of the brain and spinal 
cord during embryology contributed to the generation of this new 
classification:  
1. The venous system of the notochord and corresponding sclerotome 
extends from the basisphenoid (cavernous plexus) to the sacrum and gives 
rise to the ventral epidural drainage group. It collects the blood from 
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spongiosus bony structures and has no primary role in the drainage of the 
central nervous system.  
2. The dorsal epidural venous space is normally poorly developed at the 
spinal level. Presence of dorsally located dural sinuses intracranially is 
therefore the major difference between the venous systems of the brain and 
spine. Their formation is linked to the appearance, during evolution, of the 
dural falces and tentorium and associated with the development of the 
paleo- and neopallial structures. These sinuses result from the confluence in 
the epidural space of 2 different venous systems: the osseous system 
draining the cranial vault and the leptomeningeal system draining the brain.  
3. The veins draining the central nervous system (both spinal and cranial) are 
not related to the peripheral nerves, as are the arteries; these “emissary-
bridging veins” join the lateral epidural venous spaces as connecting 
drainage system. This leptomeningeal venous drainage has no direct 
confluent communication with the ventral and dorsal epidural venous 
plexuses, which drain primarily the skull and spine.  
They suggested that DAVFs in these 3 different areas will drain according to 
the specific role of the venous system of each region, unless there are 
associated conditions such as constraint placed on the venous outlet or 
high-flow arteriovenous shunts. These venous outlet restrictions (ie, 
occlusion or stenosis) can be either adjacent to the shunting area, most 
commonly from thrombosis, and/or remote from the shunt. 
In the VE group the following locations are encountered: “vertebral body,” 
basioccipital, sigmoid sinus, petrous pyramid, basisphenoid and adjacent 
sphenoid wings, and related dural structures.  
In the DE group, the following DAVF locations are encountered: “dorsal 
spinal epidural DAVS,” marginal sinus (dorsal portion), medial occipital sinus, 
torcular, transverse and accessory epidural sinuses, and superior sagittal 
sinus.  
In the LE group, the following locations are encountered: spinal dural 
arteriovenous shunts, marginal sinus (lateral portion- foramen magnum) with 
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the emissary-bridging vein to the condyloid vein, falcotentorial (vein of 
Galen), petrosal and basitentorial, Breschet sinus, paracavernous region 
(embryonic tentorial sinus remnants), intraorbital shunts, and lamina 
cribriformis.  
Multiplicity 
Although extensively spreading fistulas over a large territory (as those of the 
transverse-sigmoid sinuses), are not infrequent, real multiple DAVFs at 
distinct sites are relatively rare. The incidence of multiple lesions was 6.7% 
and 8.1 in two large series of patients with DAVF respectivelly. (16, 52, 60, 70, 145-148) 
Some explanations for the development of multiple DAVFs have been 
proposed. One is based on the hypothesis that the venous drainage of a 
CDAVF may cause turbulent flow or stagnation in the distant venous sinus, 
resulting in thrombosis of the sinus and development of other DAVFs. 
Thrombosis of a dural sinus at several sites caused by, for example, 
hypercoagulative state may also lead to the development of multiple DAVFs.  
As only venous hypertension unaccompanied by sinus thrombosis can cause 
the development of DAVF, elevated sinus pressure caused by initial DAVF 
can also result in the formation of multiple new DAVFs at other sites. (149) 
Van Dijk et al (150) in a group of 284 patients found multiple shunts in 8.1% of 
all cranial dural AVFs. Multiplicity was associated with a higher percentage of 
CVD, yielding a higher risk for hemorrhage. 
 
7. PATIENTS and METHODS 
This series includes 157 consecutive adult patients who were evaluated and 
treated at our institution in a 15 years period between January 1995 and 
December 2009. The primary purpose of this study was to evaluate the 
results of the endovascular treatment. Patients treated before 1995 were 
excluded because of difficulties to collect complete data. A retrospective 
analysis of hospital and outpatient charts and angiographic and imaging 
studies was undertaken. The angiographic-operative images of 62 patients 
(39%) could not be accessed; therefore the data for those patients were 
collected from the history chart, operative report and CT-MR imaging. Data 
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about Age, Sex, Interval from symptoms to treatment, Presence of Single or 
Multiple lesions, potential Predisposing factors, Presentation, Imaging other 
that angiogram findings, Location, Arterial Supply, Venous drainage, 
Classification according to the venous drainage pattern, Classification 
according to the development of the epidural venous anatomy, Venous outlet 
abnormalities (as thrombosis, stenosis or other), Management (endovascular, 
surgical, radiosurgical, combination or conservative), kind of Anesthesia, 
Approach (transarterial, transvenous, other or combination), Materials used 
for embolization, No of Sessions per patient, Immediate postoperative 
Angiographic result, Early postoperative Clinical outcome, Operation 
Complications, Peri-operative medications administered, Co-morbidities, 
Follow-up period either clinical alone or in combination with imaging modality 
(MRI, DSA), and Outcome Changes during Follow-up were collected.  
 
8. RESULTS  
 
All patients underwent selective catheter angiography to document the 
diagnosis and reveal the particular features of the fistula. Patients treated by 
endovascular embolization underwent superselective arteriography before 
treatment and control arteriography immediately after treatment as well as 
postoperative MRI before discharge.  
There were 67 women and 90 men. Their age ranged from 22 to 82 years, 
with a mean age of 57 years. 
The interval from initial presentation of symptoms presumably related to the 
fistula, until treatment was recorded in 61 patients and varied from 1 week to 
10 years, with a mean interval of 16.2 months.  
Factors that could be considered as predisposing were recorded in only 17 
patients (11%). History of head surgery related to the location of the fistula 
was reported in 4 patients, severe upper respiratory infection in 3 patients, 
documented sinus thrombosis in one patient, incompletely embolized pial 
arteriovenous fistula in one patient. In 8 cases a history of head injury was 
recorded. In 3 of them a severe trauma was referred 6, 10 and 30 years 
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before, respectively.    
In 47 patients the fistula was presented with tinnitus alone and in another 13 
patients tinnitus was combined with headache and dizziness (38% 
combined). In 31 patients (20%) the lesion was manifested with hemorrhage, 
either SAH or ICH or IVH or combination (one of these patients presented 
exophthalmus and chemosis prior to the bleeding). Thirteen patients had 
orbital signs alone as exophthalmus and chemosis. In another 9 patients the 
orbital signs were accompanied by tinnitus with (in 5 pts) or without 
headache.  In another 11 patients the orbital signs were combined with 
diplopia due to ophthalmokinetic nerve palsy whereas 3 more patients 
presented nerve palsy and tinnitus alone without any orbital manifestation. 
From the group of patients with prominent orbital manifestations (13+9 pts), 
4 patients presented impaired visual acuity (1 with glaucoma), whereas from 
the group of ophthalmokinetic nerve palsy plus orbital signs (11 pts) 2 
patients presented impaired visual acuity (1 with glaucoma). It total 23% of 
the patients presented some combination of “orbital” symptoms. Fourteen 
patients (9%) presented focal neurological disorder attributed to local - 
regional venous congestion or mass effect from a large varix. In this group, 3 
patients with progressive cervical myelopathy are included. Five patients 
presented only with epilepsy.  Two patients presented with congestive 
venous encephalopathy syndrome, 1 patient with dementia, 2 more patients 
with headache only, 1 patient with prominent frontal veins accompanied by 
dizziness and occasional tinnitus. For 2 patients the lesion was discovered 
incidentally and for another 3 patients no data in relation to the clinical 
presentation were found. 
 
8.1 Classification of the CDAVFs in our series 
Classification of CDAVFs according to location is sometimes a very difficult 
task first because dural fistulae often extent to a certain length along 
adjacent sinuses and second because what we call transverse sinus for 
instance as a distinct location with defined limits is actually just a segment of 
a continuous draining system with often morphologically undistinguishable 
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borders with the superior sagittal sinus or the ipsilateral tentorial adhesion.  In 
complex and extensive lesions the determination of the exact location is 
often even more problematic.   Yet the definition of multiplicity may be 
questionable in such lesions. According to that and in order to preserve 
accuracy we list our material according to the exact location avoiding round 
groups. 
8.1.1 According to topography 
Twenty-seven patients had a dural fistula limited to the right or left 
Transverse sinus, 9 patients had a fistula in the Sigmoid sinus, 15 patients in 
ipsilateral Transverse and Sigmoid sinuses, 24 in the Cavernous plexus (3 of 
them bilateral), 10 in the Tentorium (either supra- or infra-tentorial), 7 in the 
Convexity (either supra- or infra-tentorial) without involvement of sinuses, 7 in 
the Jugular bulb, 4 in the foramen Magnum, 5 in the Torcula, 3 in the Ethmoid 
area, 2 in the Hypoglossal canal, 2 in the SSS, 7 sub or infratentorial 
(petrosal), 2 with involvement of Transverse and Superior Sagittal sinuses, 2 
in Sigmoid sinus and Jugular bulb, 2 in the Jugular bulb and Hypoglossal 
canal, 2 in the Torcula and Tentorium, 2 in the Transverse sinus and Torcula, 
2 Temporobasal, 1 in Transverse sinus and contralateral Sigmoid sinus, 1 in 
bilateral Transverse sinuses, 1 in Transverse sinus and posterior fossa, 1 in 
Transverse sinus bilaterally, Torcula and Occipital sinus, 1 in Transverse 
sinus, Sigmoid sinus and SSS, 1 in Jugular bulb, Sigmoid sinus and IPS, 1 in 
Jugular bulb and IPS, 1 in Jugular bulb, Sigmoid sinus and Hypoglossal 
canal, 1 in Torcula and Straight sinus, 1 in the Tentorium and Falx, 1 in the 
SSS and Tentorium, 1 in the Convexity and the Transverse-Sigmoid sinus 
transition, 1 in the Convexity and SSS, 1 in the Cavernous plexus and 
petrosal apex, 1 in the Optic nerve sheath, 1 connecting the Ophthalmic 
Artery to the Ophthalmic vein, 1 in the Cerebellomedulary cistern, 1 
Temporopolar, 2 in the Sphenoid wing, 1 Osteodural of the Orbital apex and 
Sphenoid wing, 1 in the Jugular bulb as predominant location with the whole 
base involved, 1 in bilateral Jugular bulb, foramen Magnum, Clivus and 
Cavernous plexus. 
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8.1.2 According to venous drainage 
The number of each type of venous drainage according to Borden and 
Cognard classiffication is summarized in table 2. 
Eighty-three patients (53%) presented CVD in the initial angiographic 
investigation whereas almost one third of the whole population had 
exclusively CVD. 
8.1.3 According to the epidural space 
Fistula localization was divided into the three groups, ventral epidural (VE), 
dorsal epidural (DE) and lateral epidural (LE) groups. In 52 patients the 
CDAVF was located in the VE group, in 45 patients in the DE group and in 38 
patients in the LE group. Sixteen patients had a fistula extending into both VE 
and DE spaces, 6 patients in both DE and LE.  
The clinical presentation in relation to the above classifications is presented 
in the table 3. 
We defined aggressive symptoms those related to either focal or global 
neurological disturbance attributed to a CNS disorder hemorrhagic or non-
hemorrhagic (paresis, aphasia, ataxia, seizures etc) whereas we describe as 
benign symptoms those related to local factors outside or non directly 
related to the CNS, as venous congestion in the orbita with or without cranial 
nerve deficit, tinnitus, headache etc.  
One hundred and one patients (2 patients with incidentally discovered lesions 
are included) were presented with benign symptoms and 53 patients with 
aggressive symptoms 
There were 3 cases with unknown presentation and the following 
angiographic features: one belonging to the LE group with B3CIII grades, one 
to the DE group with B1CI grades and one DE+VE, B2CIIb. 
Regarding epidemiologic characteristics of the populations carrying lesions 
in the various epidural spaces we found some differences. In the LE group 27 
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of 37 patients (73%) were men and the mean age was 54.4 years. In the VE 
group the 31 of 54 patients (57%) were females and the mean age was 61.3 
years. In the DE group 26 of 45 patients (58%) were men and the mean age 
was 55 years. In the VE+DE group 8 of 15 patients (53%) were men and the 
mean age was 57.7 years. In the DE+LE group all patients were men with 
mean age 47.4 years. As we mentioned in the introduction, children were not 
included in this study. 
Analysing the relation between venous drainage according to Borden 
classification, clinical presentation (benign versus aggressive) and venous 
outlet abnormality (VOA – Thrombosis, Stenosis related or not to partial 
thrombosis, Dilatation, Varix) we found that 29.5% of lesions grade B1, which 
were presented with benign symptoms, had some kind of VOA. In the B2 
group a 52% of the benign presentation subgroup had some type of VOA 
whereas a 70% of the aggressive presentation group had some type of VOA. 
The group of B3 grade with aggressive presentation consisted of 41 patients 
with half of them having a VOA and most of these being a varix (80% present 
– in 2 cases in combination with Stenosis or Thrombosis of the venous 
outlet). 
Analysing the relation between venous epidural spaces, clinical presentation 
and venous outlet alteration we found that in the VE group 5.7% of the 
patients presented with aggressive symptomatology. In addition, 29% of the 
cases with benign presentation had some VOA whereas the 66% of the 
cases with aggressive presentation had some VOA. In the DE group, 37.7% 
of the patients presented with aggressive symptoms and the 46% of the 
benign presentation cases had some VOA whereas in the aggressive 
presentation subgroup the 70% had some VOA.  In the LE group 86% of the 
patients were presented with aggressive symptoms and the 42% of the 
aggressive presentation cases had a VOA all of them being a varix (in one 
case combined with stenosis). None of the group of patients with lesions in 
both VE and DE spaces was presented with aggressive symptoms, whereas 
half of them presented some VOA, mostly stenosis. 
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All shunts of the LE group presented CVD (100%) and 37% of the patients 
had a VOA. Ten patients of the  VE group had CVD (20%), 6 of them with 
downstream sinus thrombosis or post thrombotic changes as stenoses, 1 VE 
without VOA but high flow and 3 without any detected VOA (30% of those 
with CVD). In total, 23 patients of the DE group had CVD (49%). Of them 14 
patients had a VOA, 7 patients were without VOA and 1 case without VOA 
but high flow. 
8.2 Multiplicity 
Multiplicity in extensive dural fistulas was often difficult to detect. We defined 
multiplicity as clear presence of distinct arteriovenous shunts.  
One hundred forty-two (95%) patients demonstrated a single fistula, 10 
patients had multiple lesions (in 2 of them the whole skull base was involved) 
5 patients had bilateral lesions (3 at the cavernous plexuses and 2 at the 
transverse sinuses). 
According to Epidural space location there were 16 patients with fistulas 
extending in both Ventral and Dorsal epidural spaces and another 5 patients 
with lesions in Dorsal and Lateral epidural spaces. 
8.3 Technical Aspects 
 
8.3.1 Embolization Procedure  
All procedures were performed on a biplane angiographic unit. Percutaneous 
femoral artery catheterization was used to achieve access in all patients. 
Patients were not systematically heparinized. Standard coaxial techniques 
were used. The Valavanis catheter 5F was constantly used as both 
angiographic and guide catheter, which was navigated, into the appropriate 
parent vessel (external carotid artery, internal carotid artery, or vertebral 
artery). Microcatheters were then advanced into the selective branches, and 
superselective angiography was performed on the target branch or branches 
for embolization. Analysis of pre-embolization angiogram routinely involved 
identification of the following: 1) arterial feeders, 2) the fistulous connection, 
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3) venous outflow, 4) normal sinuses, 5) venous pouches, 6) visible and 
occult extracranial-to-intracranial anastomoses, and 7) visible and occult 
supply to cranial nerve vasculature. Knowledge of the occult anastomoses is 
especially important because these connections can remain angiographically 
silent until the moment the embolic material is injected.  
An Elite 1.5F flow-directed microcatheter was subsequently navigated over a 
microwire (Mizzen preferably or lately Mirage .008) to reach the distal aspect 
of the pedicle supplying the DAVF. Microcatheter angiography was then 
performed to confirm optimal positioning. The microcatheter was then 
flushed with 10 mL of Dextrose 0.5. Glue NBCA was typically used for 
embolization usually in high dilution permitting better penetration to the 
venous side of the shunt. The mixture of glue and Lipiodol was agitated 
mechanically for at least 3-5 minutes before use to obtain homogeneity.  
Selected branches were embolized with NBCA using plain x-ray. A small 
amount of initial reflux usually would not influence the progress of injection. 
Excessive reflux, however, was avoided to prevent the occlusion of proximal 
normal vessels and to make the removal of the microcatheter feasible. 
Whenever unwanted reflux or flow into non-targeted areas was observed, 
injections were briefly held or stopped. These pauses seemed to allow glue 
to polymerize at those areas, diverting the newly injected glue deeper 
forward.  
 
8.3.2 Anaesthesia 
Fourteen of the first patients of this series were operated under local 
anesthesia. Soon it became clear that general anesthesia was necessary 
mainly for the safety of these operations as this is valid for most of the 
endovascular operations today. One patient was operated on under sedation 
and the rest operations were undertaken under general endotracheal 
anesthesia. Routine postoperative care was performed. All patients except 
the acute bleedings were maintained normotensive in an ordinary wardroom. 
Perioperative medications were used on a case-by-case basis.  
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8.3.3 Sessions 
Overall, 189 procedures were performed to treat 154 patients, with an 
average of 1.2 sessions per patient and max 4 sessions per patient. One 
hundred and thirty-two patients (86%) were treated with a single 
endovascular procedure whereas 22 patients were treated with staged 
procedures, of them 13 patients were embolized in 2 sessions, 6 patients 
were treated in 3 sessions whereas for 3 patients 4 sessions were required. 
Three of our patients have been treated before (in a total of 6 embolization 
sessions for all 3 patients) in other institutions. 
 
8.3.4 Approaches - Transarterial, Transvenous, Combined 
In one hundred and sixty-one (85%) sessions the transarterial approach (TA) 
was exclusively used. In 3 of them balloon assistance was used for 
protection of the parent vessel during occlusion of tiny internal carotid 
feeders. In 17 sessions (9%) the transvenous (TV) approach was used 
exclusively. This was applied mainly for cavernous plexus lesions and 
occasionally for some lesions in the transverse or/and sigmoid sinus. 
Combination of TA and TV approach in the same session was required in 11 
cases. In one of the above cases with cavernous plexus lesion a transvenous 
approach was tried out but due to stenosis of the angular artery it was 
aborted and only TA approach was used. 
8.3.5 Embolic Materials used for Embolization of CDAVFs 
In 45 of 154 lesions, NBCA alone was used. In another 55 lesions NBCA was 
used with PVA as supplementary material for feeders, which persisted after 
glue injection and were not selectively approachable. Therefore in 100 
patients (65%) glue was used as the only or main embolic material. In 
another 27 cases (17.5%) pertaining either to lesions with both very tortuous 
and diffuse supply (this was the case of 11 transverse sinus shunts with main 
supply from distal occipital branches) or to lesions with minimal supply from 
tiny and/or dangerous feeders, solely PVA was used. In 15 cases (10%), 
mainly referring to cavernous plexus lesions, Coils were used as the only 
embolic material. A combination of the above three materials (NBCA, Coils, 
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PVA) was used in 12 cases. PVA was delivered in 5 of the 12 cases, in all of 
them as supplementary material. In 6 of the 154 lesions balloon assistance 
was employed. 
 
8.4 Applications and Goals of endovascular treatment 
 
8.4.1 Curative Treatment 
Endovascular treatment should be considered the treatment of choice for 
CDAVFs since can be a curative treatment for the majority of cases as long 
as a permanent embolic agent can be pushed to the venous collector of the 
lesion or a venous approach is applicable. This was achieved in the 68% of 
our cases. 
 
8.4.2 Palliative Treatment 
Palliative treatment should be reserved for very extensive lesions without a 
chance of complete eradication or for lesions, which involve either long and 
tortuous arterial feeders without a possibility of approaching the shunt zone 
to deliver a permanent embolic agent or/and a venous approach is not 
feasible.  
 
8.4.3 Preoperative Treatment   
Practically this is not an application of the endovascular treatment. In our 
series in one case and only after failure of palliative treatment of a very 
extensive shunt to control the patient’s symptoms in the long-term, a surgical 
occlusion of the transverse-sigmoid sinuses was performed, combined with a 
venous by-pass connecting the transverse sinus proximal to its occlusion 
with the jugular vein. In 1 more case surgical intervention was also employed 
after a subtotal endovascular occlusion, aiming to a complete surgical 
eradication of the lesion. 
 
8.5 Results of Endovascular Treatment 
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8.5.1 Angiographic results 
Angiographic results were defined the immediate results in the final control 
angiography.  
Complete occlusion or anatomic cure of the AVF was strictly considered the 
absence of any arteriovenous shunt in the late angiographic phases. As 
subtotal occlusion, was defined an above of 90% occlusion rate and an even 
faint opacification of the venous drainage in the late arterial phase. Extensive 
occlusion was considered an occlusion of approximately 70-90% of the 
shunt. Below 70% occlusion of the shunt was reported as partial occlusion. 
We should notice that some cases with an angiographically demonstrated 
subtotal occlusion at the end of embolization, presented a picture of 
thrombosis of their shunt and draining vein/s in the subsequent MR imaging. 
In 92 of our patients (60%) a complete occlusion in one session was 
obtained. Of the 40 remaining patients who underwent just one embolization 
session, 25 patients (16%) had a subtotal angiographic occlusion, 11 
patients (7%) had an extensive occlusion and 4 patients had a partial 
occlusion. 
The remaining 22 patients had multiple embolization sessions.  
Of the 13 patients who underwent 2 sessions, 8 patients demonstrated a 
complete angiographic occlusion in the final angiogram of the second 
session. In the remaining 5 patients with 2 sessions, a subtotal occlusion was 
obtained in 4 patients and an extensive occlusion in 1 patient. 
Of the 6 patients who underwent 3 embolization sessions, a complete 
angiographic occlusion was achieved in 3 patients. In 2 patients a subtotal 
occlusion was achieved after the third session and in 1 patient an extensive 
occlusion was achieved after the third session. 
Of the 3 patients who underwent 4 embolization sessions, a complete 
angiographic occlusion was achieved in two. In the third patient a subtotal 
angiographic occlusion was achieved in all four sessions. 
By summarizing the above results, 105 patients (68%) presented a complete 
angiographic occlusion of their AVF, 32 patients (20.5%) presented a 
subtotal occlusion, 13 patients (8.5%) presented extensive occlusion and 4 
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patients (3%) had a partial occlusion (one intensively, one palliative and one 
aborted because of a complication). The exact number of patients with 
subtotal angiographic occlusion who demonstrated a thrombosis of the 
shunt and draining veins in the immediate post-operative MR was not 
precisely reported and therefore not mentioned here. 
Considering the angiographic results in relation with the venous drainage 
pattern, we obtained a complete occlusion in 47 of the 74 patients (63.5%) 
with benign lesions (Borden grade 1) whereas a complete occlusion was 
achieved in 58 of the 83 patients (70%) with aggressive lesions (Borden 2 & 
3).  
In 41 of the 105 achieved complete angiographic occlusions, NBCA was the 
only embolic material, whereas in 14 complete occlusions, coils were the 
only embolic material. In 32 achieved complete angiographic occlusions a 
combination of acrylic glue and PVA (in most of the cases as supplementary 
agent) as the only embolic materials were employed, whereas in another 4 
complete occlusions another combination of materials was used. In 14 of the 
complete angiographic occlusions, PVA was employed as the only embolic 
material.  
    
8.5.2 Early Clinical outcomes 
Regarding the early clinical outcome, a clinical cure was defined by complete 
resolution of signs and symptoms attributed to the fistula, within days after 
treatment. Patients were considered clinically improved if their symptoms 
significantly diminished after treatment without development of new 
symptoms or signs as a result of a complication.  
 
We defined immediate clinical outcome the clinical condition of the patient 
during the period of postoperative hospitalization. For most of our patients 
who were presented without severe symptoms this period corresponded with 
a time period of few days to 1 week in average. 
Ninety-one of our patients did not present a new neurological deficit 
postoperatively (NND). This refers to the patients who either were suffering of 
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some neurological deficit due to previous bleeding/ischemia or the 
presenting symptom was not permanent in nature (epileptic fit, for instance) 
or it was too early to be evaluated during the immediate postoperative period 
(as dementia or nerve paresis for instance). 
Thirty-seven of our patients showed complete disappearance of their 
presenting symptom (tinnitus in most of these cases). 
Eighteen patients had clear improvement of their presenting symptoms 
(mainly orbital symptomatology) during immediate postoperative days. 
Four of our patients presented temporary new symptoms. Two patients 
presented a new mild diplopia (in one of them due to IIIn paresis), 7 and 12 
hours postoperatively correspondingly, which subsided after 24 hours 
approximately. One more patient presented a worsening of a preexisting 
decreased visual acuity. The fourth patient presented a new and only 
epileptic fit few hours postoperatively. 
One patient presented hemiplegia as a new and permanent neurological 
deficit postoperatively. One patient presented headache and vomiting 
connected to edema in the cerebellum after embolization of a fistula draining 
into cortical cerebellar veins. He was managed by craniectomy of the 
posterior fossa and antiedematous treatment but he developed some 
cerebellar infarcts. One more patient presented X and XII nerve paresis after 
embolization of a Jugular foramen DAVF.  
One last patient who developed spasm of his SCA (feeder of the AVF) 
presented a vermis infarction after post-embolization surgery aiming to 
complete elimination of the shunt. 
 
8.6. Complications of Endovascular Treatment 
There were 4 cases of permanent neurological deficit (2.6%) due to an 
operative complication and 4 cases of temporary neurological manifestations 
(2.6%) most of them not clearly related to an operative complication. There 
was no mortality connected to an operative complication in this series. 
The first case of permanent neurological deficit is related to an unwanted 
glue migration through a non-opacified collateral, the artery of the foramen 
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lacerum to the ICA and then to MCA territory, which resulted to a severe 
infarction of the MCA. The second case with permanent deficit is related to 
an infarction of cerebellar vermis after spasm of the SCA, which occurred 
during incomplete embolization and after subsequent surgical operation for 
elimination of the lesion. The third case with permanent morbidity was a 
patient with X and XII nerve paresis after embolization of a jugular-
hypoglossal foramen lesion. 
One last patient with a torcular DAVF and cerebellar cortical drainage with 
varix vein presented two days after the embolization cerebellar signs and 
edema with later infarction presumably due to venous thrombosis. A 
decompressive craniectomy was performed plus anti-edematous treatment 
and the patient showed improvement during ensuing weeks. 
 
Two patients presented temporary diplopia few hours after embolization 
presumably related to paresis of ophthalmokinetic nerves. The first patient 
improved rapidly after 24 hours whereas the second patient recovered over 
several days. One AVF was located at the transverse and sigmoid sinus, was 
managed exclusively with PVA and clival branches of the ICA were involved 
and selectively catheterized. Similarly the other case was an ethmoidal AVF 
with supply from bilateral ophthalmic artery, was managed exclusively with 
PVA and the ethoidal arteries were involved and selectively catheterized. The 
diplopia was attributed to temporary ischemia of the cranial nerves.  
One more patient with optic nerve sheath DAVF and orbital symptoms with 
decreased visual acuity, while he showed clear improvement of the orbital 
symptoms (chemosis, exophthalmus), he presented a worsening of visual 
acuity after one day. The lesion was managed exclusively with transarterial 
approach and glue injection without complication detected during injection or 
in the control angiography. 
One more patient with a transverse-sigmoid sinus AVF who presented an 
epileptic fit for the first time postoperatively did not suffer of any detected 
operative complication. 
None of the patients with a benign lesion presented a complication and 
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related morbidity.  
 
8.7 Follow-up 
As a general rule the first postoperative imaging with CT was performed in 
the same day or the next day after the operation. MR was undertaken during 
the first 2-3 days after the operation.  
Patients were usually evaluated at yearly intervals after treatment. Some 
patients who presented complete angiographic cure of their lesion in the final 
post-operative angiogram were checked regularly in approximately 1 year 
with MR and then in approximately 2 years and in case of confirmation of the 
initial result no other control was performed. In most of the cases, an 
individualized approach regarding follow-up was applied. In total, 151 
patients were followed-up for 439 patient-years (mean 2.9 years ranging from 
1 to 15 years). For patients with known incomplete occlusion or signs of 
reccurence either clinical or imaging the strategy was defined according to 
the specific symptomatology in combination with the MR imaging. In case of 
either severe symptoms or suspicion of CVD or both, then a DSA was 
performed and further embolization was applied. Four patients with an 
angiographic complete occlusion in the initial embolization session presented 
recurrent clinical symptoms during follow-up and underwent DSA and further 
embolization. One of them presented with a new bleeding. In 3 of these 4 re-
embolized patients a complete occlusion was achived whereas in one a 
subtotal occlusion was obtained. Five more patients with an initial 
angiographic complete occlusion presented MR findings indicating a 
persisting shunt in their regular imaging follow-up without clinical 
manifestation. They are just followed-up. Thirty-five patients with an 
incomplete occlusion in the last embolization presented a dissapearance of 
vascular abnormalities (arterial feeding vessels, shunt or dilated veins) 
indicating a persisting DAVF in the follow-up MR examination (one after 
additional surgery – by-pass). For 92 patients the clinical and MR follow-up 
confirmed the known complete occlusion of their lesion, whereas for 11 
patients the MR follow-up imaging confirmed the known incomplete 
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occlusion of their shunt; one patient of this group with persistent CVD 
presented cerebral bleeding and died. The remaining 10 patients had no 
clinical worsening and 5 of them had no evidence of CVD, therefore further 
follow-up and neither new embolization nor DSA control were suggested. 
Three recently treated patients with complete occlusion achieved, have no 
follow-up examination yet, whereas one more patient with complete 
angiographic occlusion died few weeks after his admission due to a severe 
brainstem bleeding which was the presentation mode of his AV shunt. 
 
In total, of the 151 embolized and followed-up patients, 134 patients (4 
recently treated patients without f-u yet are included) demonstrated a 
complete occusion (88.7%) of their shunt and 17 patients an incomplete 
occlusion (either subtotal, extensive or partial); one patient with incomplete 
occlusion died as a result of a re-rupture of the CDAVF during f-up and one 
patient with complete occlusion of his CDAVF died as a result of his initial 
brainstem hemorrhage. 
In total 3 patients were lost to follow-up; Two of them carried a benign lesion 
(Borden grade 1) with an initial extensive occlusion in the post-operative 
angiogram and the third patient had a Borden grade 2 lesion with an 
elimination of the CVD in the post-operative angiogram (Table 4). 
 
8.8 Other therapeutic modalities – Combinations 
In this series only 2 patients both with Cavernous plexus lesions, who had 
mild orbital symptoms and slow flow in the diagnostic angiogram were 
treated with compression. One more patient diagnosed with MR in 
combination with the clinical picture, was discovered with spontaneous 
thrombosis of a Cavernous plexus fistula in the angiogram.  In this 
consecutive series of patients no other therapeutic modality alone or in 
combination was applied prior to embolization, which was the first line choice 
for all cases. In one case of extensive and complex DAVF in the area of the 
Transverse sinus and after four embolization sessions resulting in subtotal 
occlusion, by-pass surgery with occlusion of the sinus was employed. In a 
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second case and after incomplete embolization, surgical operation was 
undertaken aiming to the complete elimination of the lesion. No patient was 
refered or treated by radiation. 
 
9. DISCUSSION 
 
Many publications have been appeared in the literature during the last 25 
years regarding CDAVFs. These include angiographic predictors of 
hemorrhage (16, 22, 24, 25, 31, 71, 79, 130, 143, 151, 152) natural history (28,31,37,38,68,79,132-135) 
classification (15,18,40,62,71,130) but also various techniques and materials for 
treatment and results (34-36,38,61,167,174,221,224-286).  
Spontaneous or traumatic sinus thrombosis seems to be one the primary 
events, triggering the stimulation of angiogenesis and perhaps engorgement 
of the native microscopic arteriovenous channels that normally exist within 
the dura mater (18, 22, 47,62,129,130, 154-157) 
A history of trauma(158-165) previous surgery(20,59,16-169) or clinical states 
associated with hypercoagulability, including infection(170-172) 
pregnancy(30,119,173-175) are reported in the literature. Nevertheless the largest 
percentage of cases, as in our series do not refer any such predisposing 
factors. Factors that could be considered as predisposing were recorded in 
only 17 patients (11%). 
9.1 Angioarchitecture of CDAVFs 
The term angioarchitecture refers to the angiographically demonstrable 
vascular elements composing a CDAVF and includes the feeding arteries, the 
shunt area, the draining veins and any associated vascular abnormalities 
either involved in the aetiopathogenesis process or secondarily induced by 
the lesion. 
 
9.1.1 Feeding arteries 
The arterial aspect of the dural fistula looks more interesting for planning of 
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treatment than for their development and manifestation. This is particularly 
illustrative of the importance of the venous aspect in the understanding of 
CDAVFs. The location of the lesion determines the arteries, which supply the 
shunt in a more or less predictable way. Variations in the combination of 
expected arterial feeders apparently reflect the normal variations of the 
territory covered by each individual artery. The feeding arteries in the vast 
majority of the cases are dural branches of the external carotid artery and/or 
internal carotid artery and vertebral artery. Skin and transosseous branches 
of the external carotid artery, primarily from the distal occipital artery and 
secondarily from the posterior auricular artery and superficial temporal artery 
often contribute to the shunt. Sometimes pre-existing but small dural 
branches of Superior Cerebellar artery, Posterior Cerebral artery and Anterior 
Inferior or Posterior Inferior Cerebellar arteries are observed having 
significant contribution to the shunt, which is usually located in the tentorium, 
torcula and Transverse sinus. This was observed in 11 of our patients with 7 
lesions located at the tentorium area, 3 in Transverse sinus area and 1 in 
foramen magnum. All of them except one had CVD and aggressive 
presentation. In a minority of cases non-dural, cortical branches of the 
internal carotid and vertebral arteries are also involved. In our series this was 
observed in 4 cases (part of the previously 11 cases mentioned). Some 
notheworthy though not common characteristics of those cases were, 
multiple embolizations in one, extensive lesion with dementia in another and 
previous craniotomy in the other two.  
Dural shunts supplied even by dilated and/or multiple dural or cortical 
branches of the internal or vertebral arteries have no significant 
hemodynamic effect on the brain.  
On the other hand, symptoms potentially explainable by meningeal arterial 
steal of dural arteries supplying the cranial nerves are rarely referred. In our 
series no symptomatology attributed to such a mechanism was recorded. 
Arterial aneurysms flow-related or not are practically not encountered. This is 
most probably related to the fact that dural arteries lie in the outermost, 
periosteal layer of the dura surrounded by connective tissue. 
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A distinct group of lesions are the so-called osteodural AVFs which are fed 
by meningeal arteries and lie actually within the bone either in the convexity 
or in the skull base. (55) 
 
9.1.2 Shunt zone 
Although the arterial network of the dura of the cranial vault and base, 
primary and secondary is actually located in the periosteal layer, the 
penetrating arteries cross the border between outer and inner layer and fall 
into the capillary bed, which lies, on the inner surface of the dura. (44). The 
vasculature in the falx cerebelli, falx cerebri, and tentorium lies within the 
opposing meningeal layers of the dura that have invaginated to form these 
partitions. (138,45)  It is not clear if the capillary network of the falx and 
tentorium lies on the inner surface or not. 
In addition, histopathological reports and studies of DAVFs in serial sections 
have been scanty. We know from them that arteriovenous fistulas consist of 
small shunts between dural arteries and dural veins, which lie in the wall of 
the dural sinus, rather than direct communications between dural arteries 
and the lumen of the dural sinus. (52,53,65, 139-142) 
What we do not know is on which aspect of the dural layers the shunt zone 
lies, therefore in which microanatomic environment it is developed. In relation 
with this, it is interesting to notice that epidural hematoma is not included in 
the spectrum of the clinical manifestations of a non-traumatic CDAVF. This 
could imply that a dural “nidus” is not structurally directly associated with the 
periosteal side of the dura matter, but apparently this is not the case since 
several lesions located in the skull base area present a clear bony 
involvement. In any case the exact location of the shunting zone should be 
expected to depend on the structure of the dura and its relationship with the 
adjacent bone and leptomeninges. An arteriovenous shunt located in a 
convexity dural site should be different in terms of structure, evolution and 
clinical manifestation in comparison with a shunt located in the wall of a dural 
sinus, in the free margin of the tentorium, in the wall of a venous plexus or in 
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the transdural segment of a cortical vein. 
Histopathological studies on CDAVF speciments revealed that the essential 
abnormality was a connection between the dural arteries and the dural veins 
within the venous sinus wall, through small vessels averaging approximately 
30 µm in diameter. By using several staining methods, they confirmed that 
the vessels were part of the venous system having an incomplete smooth 
muscle layer and lacking internal elastic lamina.(46) 
9.1.3 Venous drainage 
The venous drainage of a CDAVF can employ a dural vein, a dural sinus or 
just a part or channel of a dural sinus,(143, 144) a cortical vein or a combination 
of the above. Employment of only dural veins represents the simplest form of 
a CDAVF venous drainage. The most usually encountered type of venous 
drainage is the one through a dural sinus. Sinuses can present morphological 
abnormalities (VOA) as occlusion corresponding to sinus thrombosis, 
stenosis related or unrelated to previous thrombosis, dilation or mixed 
changes located either in the proximity of the lesion or in a remote site. 
Moreover, venous sinuses and particularly the SSS normally present a 
multicompartmental structure and often one or some of these channels are 
exclusively involved in the drainage of the lesion offering thus a chance for 
superselective transvenous obliteration of the shunt leaving the sinus patent.  
Cortical venous drainage can give to the venous system a phlebitic 
appearance with slow or even reversed flow or can present significant 
varices or/and stenoses. (153) These different patterns of appearance 
represent the degree of adaptation of the venous system and are determined 
by the time and progress rate of the shunt, the amount of the flow and the 
intrinsic capability related to the collateral pathways of the system to 
compensate the retrograde flow. Otherwise, CDAVFs developed in relation to 
the 3 epidural areas will predictably drain according to the specific role of the 
venous system of each region, unless there are associated conditions such 
as constraint placed on the venous outlet or high-flow arteriovenous shunts 
or other unknown factors that contribute to the re-direction of the flow to 
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alternative draining channels.   
9.2 Association with other vascular or neoplastic lesions  
Only limited information is available concerning association of CDVAFs and 
intracranial aneurysms. After an initial description in 1987(176) only some 
sporadic reports have appeared. (177-180) Suzuki et al reported an incidence of 
13% in their series of consecutive 46 patients with dural AVFs. They were 
rather associated with shunts of the anterior cranial fossa and cerebral 
convexity.  
Few case reports have focused on the coexistence of CDAVFs and moya-
moya phenomena speculating on a potentially shared association with dural 
angiogenesis (181-183) 
Dural and pial arteriovenous fistulas are uncommonly associated. Most of the 
few reports come from the Toronto group. They proposed that venous steal 
effect in the dural sinus secondary to the high-flow dural arteriovenous shunt 
induced the pial arteriovenous fistulas.(184-187) 
And last, it is known the association between meningiomas and other benign 
or non-benign tumors with CDAVFs. Several publications have focused on 
the coexistence and potential etiologic relation between the two entities. (188-
196)  
In our series we observed 5 patients with a coexistent vascular malformation 
or anomaly. One patient suffered of multiple cavernomas of the cerebellum 
associated with a tentorial-torcular DAVF. One patient had a cavernoma, a 
DVA and a venous hemangioma of the maxilla associated with a 
temporopolar CDAVF. Two patients had associated pial AVFs (one of them 
with multiple dural and pial shunts along the SSS) and one patient had a 
DVA.  
One more patient suffered of HHT with a family history and a polmunary 
shunt operated on in the past. 
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We also observed 5 patients with neoplastic disease, 3 of them being a 
meningioma topographically associated with the DAVF and one patient with 
Multiple Myeloma with a paraganglioma which is an extremely rare 
association (288). 
9.3 Presentation 
Regarding the clinical presentation, a correlation between the venous pattern 
of CDAVFs and an aggressive clinical course has been established. (16,18,21-31) 
Fifty-one of 53 (96%) of our cases with aggressive clinical presentation had a 
CVD in the angiogram. The remaining 4% corresponds to 2 patients, one of 
them presented initially with SAH and treated partially elsewhere and the 
other one with a SSS located lesion presented with one single episode of 
epilepsy. Only a 61.5% of patients who were found with a CVD in the 
diagnostic angiogram had presented an aggressive clinical behaviour. As the 
presence of a bruit is frequently associated with CDAVFs involving the 
transverse-sigmoid sinus (21,33, 80, 170, 218) in our series 81% of the patients with 
lesion involving transverse and/or sigmoid sinus were presented or were 
complaining for tinnitus. Tinnitus was also a characteristic symptom for 
lesions located in the Jugular foramen. Fifteen of sixteen patients (94%) with 
lesions involving the Jugular foramen had tinnitus as one of the presenting 
symptoms. Also 9 of 26 patients (35%) with lesion involving the Cavernous 
plexus and 2 of the 3 patients (65%) with lesion of the Sphenoid wing had 
tinnitus among other symptoms at presentation. All 3 cases with dementia-
like syndrome related to venous congestion-hypertention were patients with 
lesions of Transverse-Sigmoid sinus. Furthermore, drainage of cavernous 
sinus CDAVFs into the orbital plexus produces the "red eye" spectrum of 
symptoms from a mild chemosis and proptosis to severe exophthalmos with 
ophthalmoplegia and glaucoma (219-221) 
 In 21 of 24 patients with Cavernous plexus DAVF this spectrum of symptoms 
was the main clinical manifestation whereas 3 of the patients were presented 
with tinnitus and diplopia with (in 2) or without headache. For 5 other patients 
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with lesions located not in the cavernous plexus these signs constituted the 
presenting picture. In 2 of these patients the lesion was located in the 
jugular-hypoglossal foramen, in one patient in the temporopolar dura and in 
another 2 patients in the orbita. 
One of the last and important contributions (222) of P. Lasjaunias was the new 
classification of CDAVFs according to the anatomy of the epidural venous 
system and the location of the fistula. In that publication by Geibprasert et al 
(40) a new step was made towards a better understanding of the anatomical 
characteristics and the clinical manifestations of such lesions. They found 
that the ventral epidural group showed a female predominance, more benign 
clinical presentations, lower rate of cortical and spinal venous reflux, and no 
cortical and spinal venous reflux without restriction of the venous outflow. 
The dorsal epidural group had a lower mean age and a higher rate of 
multiplicity. The lateral epidural group presented later in life with a male 
predominance, more aggressive clinical presentations, and cortical and 
spinal venous reflux without evidence of venous outflow restriction. 
Therefore, dural arteriovenous shunts predictably drain either in pial veins or 
craniofugally depending on the compartment involved by the dural 
arteriovenous shunt. Associated conditions (outflow restrictions, high-flow 
shunts) may change that draining pattern. The significant differences 
between the groups of the new classification support the hypothesis of 
biological and/or developmental differences in each epidural region and 
suggest that CDAVfs are a heterogeneous group of lesions 
In our series most of the above observations were confirmed. 
The VE group of lesions had the more benign presentation with only 5.7% of 
them presenting with aggressive symptomatology. The female predominance 
of 57% did not reach statistical significance. 
Regarding the relation of the DE group with multiplicity, in fact all 20 cases 
with multiple lesions had a DE component, 15 of them with an additional VE 
component and 5 of them with a LE component. The age features of the DE 
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group could not be compared due to non-inclusion of children in the present 
series.  
The LE group presented a male predominance (73%) as in Geibprasert et al 
series. The 86% of them had an aggressive presentation and 58% of the 
aggressive lesions had no VOA. 
There were also a percentage (approx. 1/3) of patients in groups DE and VE, 
where a CVD was observed without any indication of high flow or restriction 
in the venous drainage downstream to the shunt either due to stenosis or 
thrombosis (Table 4). 
The fact that nearly 40% of the lesions with CVD were presented with non-
aggressive symptoms may indicate that these particular lesions might have a 
different natural history presumably due to their intrinsic capacity to 
compensate the hemodynamic stress of the arteriovenous shunt.  
9.4 Indications for Endovascular Treatment 
The basic decision-making process regarding active treatment versus 
conservative treatment (compression when applicable, or observation) is 
based on the patient’s neurologic and general condition at presentation, the 
evaluation of natural risks according to the angioarchitecture of the lesion 
and the anticipated results of a conservative approach versus potential risks 
or the different treatment modalities.  
The patient’s neurologic and general condition at presentation plays an 
important role. Patients presenting with ICH sometimes require emergent 
hematoma evacuation. In our series for none patient such an operation was 
necessary. Depending on the hemodynamic conditions the entire shunt and 
draining veins may be fully or partially compromised or thrombosed in the 
early acute phase.  Regardless of the indication for urgent embolization, 
cerebral angiography should be repeated after resorption (or evacuation if 
indicated) of a hematoma to demonstrate the true angioarchitecture of the 
lesion. Embolization in a patient being investigated angiographically in the 
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acute phase of cerebral hemorrhage is indicated if a pseudoaneurysm, varix, 
CVD or severe venous congestion is being idendified.   
Since cranial dural arteriovenous fistulae represent a heterogeneous group of 
pathologies with different angioarchitecture and risks, the indications for 
treatment cannot be the same for each group or case. The primary goal of 
treatment of a cranial dural arteriovenous fistula with cortical venous 
drainage is the prevention of severe neurologic deficits either as a potential 
result of a rupture or as consequence of cortical venous congestion and 
infarction. On the other side the primary goal of a benign cranial dural fistula 
is the alleviation of persistent and irritating symptoms as tinnitus or more 
disabling ones as orbital symptoms – chemosis and exophthalmus - with or 
without nerves palsy and glaucoma.  
The patient’s tolerance to otherwise mild symptoms and his attitude towards 
active or conservative treatment play often a decisive role in the management 
of benign lesions. Generally, conservative treatment and follow-up in benign 
lesions with mild or none symptoms is the management of choice. 
9.5 Diagnosis and Follow-up 
Six-vessel angiography (bilateral internal, external carotid, and vertebral 
arteries) is the examination of choice for diagnosing and classifying (197-199). 
The ability to define the arterial and venous patterns significantly increases 
the diagnostic value of angiography compared with computed tomography or 
magnetic resonance imaging (200-206) 
Magnetic resonance angiography and venography provide a noninvasive 
method for defining dural arterial and venous anatomy (77,207,208) but the 
techniques have significant limitations. Resolution is suboptimal compared 
with that of conventional angiography, and flow dynamics of the lesion are 
poorly defined. Despite its small but definite risk (209) cerebral angiography 
remains the "gold standard" for assessing CDAVFs. 
However the modality that can be used for follow-up of treated patients is a 
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different issue. As recent publications (210-211) and our experience have shown 
MR angiography techniques offer a reliable and non-invasive alternative to 
the digital angiogram. In our institution conventional MR imaging, MR 
angiography (3D-TOF-MRA), and source images, have been used for the 
visualization of intracranial DAVFs. The crucial question that could be 
discussed with regard to the follow-up imaging modality is whether such an 
MR imaging can reliably rule-out the presence of a small and slow flow 
residual or the presence of CVD. Based on the published reports the answer 
is apparently negative at least for the first part of the question. However, in 
an asymptomatic patient such a small and slow flow shunt is rather benign 
without clinical significance and simply requires follow-up to exclude 
progression to a higher-grade lesion. Therefore, the absence of evidence of 
any residual requires either the verification of digital subtraction angiography, 
which can then safely lead to the suspension of further controls, or 
alternatively the repetition for several years of the non-invasive MR control. 
Regarding the second part of the question it is evident that dilated cortical 
veins that usually signify CVD can be reliably detected by MRI-A. Non-dilated 
or slightly dilated cortical veins involved in a DAVF certainly have been 
observed but again they can be detected with flow sensitive MR techniques 
and moreover their significance in terms of risk for aggressive manifestations 
is questionable. In any case, at least at the moment DSA remains the gold 
standard imaging not only for diagnosis but also for follow-up. (212-214) 
Other authors have proposed that duplex sonography can be used as 
screening tool with high specificity (99%) and moderate sensitivity (51% to 
63%) for diagnosis of CDAVFs or with high diagnostic sensitivity and 
reliability for detecting DAVF in patients with pulsatile tinnitus. (215,216,217) 
In our series all patients underwent a 6-vessel cerebral DSA at the stage of 
initial diagnosis. All patients underwent brain MRI-A for evaluation in addition 
to the diagnostic CT scan performed nearly in all acutely presented cases. In 
43% of patients an initial diagnosis was made based on the MR findings. In 
10 cases the initial diagnosis was made by U/S and was confirmed by either 
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MRI or/and DSA. In 5 cases only after DSA was the lesion revealed. For the 
rest of the cases no clear data were found. 
9.6 Treatment and Complications 
The decision of how to deal and whether to operate on a CDAVF should be 
based on the patient's clinical presentation, natural history, lesion 
angioarchitecture, and location of the lesion. Certain locations (i.e. lateral 
epidural space) and/or angiographic findings (i.e. presence of cortical venous 
drainage) are associated with a risk of hemorrhage and demand treatment. 
The primary goal of treatment should be elimination of the cortical venous 
reflux if any and furthermore complete obliteration of the lesion. As 
experience has shown, complete and permanent obliteration of a CDAVF by 
endovascular approach is achieved by complete obliteration of the venous 
component of the lesion. This is a crucial aspect of the treatment of CDAVFs 
and requires that the embolic material promote the complete thrombosis of 
the venous part of the shunt. It explains also why some materials as PVA fail 
to induce permanent cure and present a high rate of recanalization. In some 
cases, however, palliative treatment for control of symptoms in cases of very 
complex and/or extensive lesions is a reasonable alternative. To relieve the 
symptoms, especially for patients in poor general medical condition, a 
palliative endovascular procedure even with a non-permanent embolic agent 
offers in some cases an acceptable therapeutic option with inconsiderable 
risk. Generally the risks of endovascular treatment include mainly infarction of 
cranial nerves and stroke whereas the limitations are related to the difficulty 
to access very tortuous arterial feeders (transarterial approach) or very 
dilated and fragile venous collectors (transvenous approach) (140, 223-237) 
We reviewed all publications focusing to the endovascular treatment of 
cranial dural arteriovenous fistulas during last 25 years, which included more 
than 20 cases each (Table 5). We found 27 publications (35, 132, 238-262) in the 
English literature until 2009 presenting a total of 1213 cases of CDAVFs 
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treatment. Only 3 of these publications included more than 100 patients 
(135,141,150 patients respectively) with all the rest 24 publications with less 
than 60 patients each. These series are very heterogeneous in relation with 
almost all relevant data as location, venous drainage pattern, management, 
approaches and materials used. Therefore proper statistical analysis is not 
really applicable. Nevertheless, some rough conclusions can be drawn.  
Regarding location of CDAVF, 14 publications reported on single-location 
lesions (6 of them in Cavernous plexus, 6 in Transverse-Sigmoid sinuses, one 
in Anterior fossa and one in the Tentorium) whereas the remaining 13 
publications included lesions from various locations. Twenty-three of these 
papers reported data about venous drainage pattern. Three of them included 
only cases with cortical venous drainage whereas the twenty series included 
cases with various venous drainage patterns. In 14 of the publications data 
about venous outlet abnormalities are reported. In the vast majority 
thrombosis of the involved sinus is reported as the prevalent venous 
alteration.  
Regarding treatment, which is the main purpose of this study, 973 of the 
1213 cases were treated only with embolization (80%). Five publications refer 
the transarterial approach as the only approach used in the endovascular 
treatment of the included cases. In 18 series both transarterial and 
transvenous or combination were used.  Only 13 publications reported data 
about number of sessions needed for achieving the goal of endovascular 
treatment. The mean number of embolization sessions ranged from 1 to 2.5 
sessions per patient. 
The materials used were reported in details in 19 series. In 15 series a 
combination of materials as NBCA, PVA and Coils were used in the majority 
of the cases treated. In only 4 of them a single material was used (1 series 
with coils as exclusive material and 3 series with onyx). 
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The immediate post-procedure angiographic outcome is described in 20 
publications. From the single-location series the complete occlusion rate in 
the cavernous plexus lesions ranged from 37% (this percentage reached the 
89% during a follow-up period of 2-16 months without additional 
interventions) to 90%. The complete occlusion rate for transverse-sigmoid 
sinus lesions ranged from 36% to 52%. Whereas for tentorium and anterior 
fossa the percentage of complete immediate angiographic occlusion was not 
reported. From the mixed-location series the complete occlusion rate ranged 
from 20% to 91%.  
The early clinical outcome is incompletely described in 20 publications. In the 
single-location group series the percendage of early clinical cure ranged from 
30% to 87%. This percentage reached the 96% after a 1-4 months follow-up 
period in one series of cavernous plexus lesions. For the mixed-locations 
group the percentage of early clinical cure ranged from 30% to 83%. 
The operative complication rate and the related neurological morbidity 
ranged from zero to 23% transient and 12.5% permanent neurological 
deficit. Both high percentages of transient and permanent morbidity were 
appeared in series with Onyx as the main or exclusive embolic material. No 
deaths were reported. 
Only 13 publications provided, though incomplete, clinical or imaging follow-
up data. The follow-up interval ranged from 3 months to 56 months.  
Our series has certain particular features. It is one of the largest series of 
DAVF including lesions from various intracranial locations, focusing on 
endovascular treatment, operative results and complications and having a 
long-term follow-up. It comprises of 154 consecutive patients treated 
exclusively endovascularly with the exception of 2 cases where surgical 
intervention was also employed aiming to the complete eradication of the 
lesion and 3 cases where conservative treatment was applied. In another 
case of torcular DAVF a craniectomy was applied in the early post-operative 
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period, aiming to a decompression of the posterior fossa and not to the 
elimination of the lesion itself.  
If we examine the patients endovascularly treated in the present series 
divided in two groups, the “benign” group (Borden gr 1) and the “aggressive” 
group (having CVD) comprised of 71 and 83 patients respectively, then we 
should notice that 63.5% of the “benign” group had an anatomic cure in the 
post-operative DSA without complication and permanent morbidity. On the 
other hand, 70% of the patients of the “aggressive” group had an anatomic 
cure in the post-operative angiogram with all permanent-morbidity cases 
belonging to this group.  
During the follow-up period 86% of patients with benign lesions 
demonstrated a complete occlusion (2 were lost to f-up) whereas 88 % of the 
aggressive group demonstrated a complete occlusion (one was lost to f-up). 
Therefore, the total complete occusion rate was 87%. 
Otherwise, 128 (83%) of the 154 patients treated endovascularly presented 
either clinical cure or no new neurological deficit in case of preexisting 
deficits. Another 18 patients presented clear early improvement of their 
symptoms and 4 more patients at discharge after subsidence of post-
operative temporary neurological manifestations. Four patients presented a 
clinical worsening related to a complication. One patient died during the 
initial hospitalization due to his presenting ICH. Two patients presented 
cerebral bleeding during f-up. The first patient had a subarachnoid-subdural 
hemorrhage without new neurological deficit whereas the second patient 
died. In total, 96.7% of our treated patients presented clinical cure or 
improvement of the presenting symptoms at discharge, without new 
neurological deficits. 
Four patients (2.6%) suffered a complication. In one of these cases, spasm of 
the superior cerebellar artery was only obvious before the end of the 
procedure. The immediate post-embolization employment of an open 
  50 
surgical approach aiming to a complete elimination of the lesion and resulting 
in a cerebellar infarct makes the exact estimation of cause and effect difficult. 
Nevertheless we included this case in the endovascular treatment-related 
complications due to the potential relation of cerebellar infarct with the 
spasm of the SCA. These percentages of successful treatment are among 
the highest with an associated complication rate among the lowest. 
9.7 Materials used and long-term result 
Recently a new embolic material called Onyx (ev3 Neurovascular, Irvine, CA) 
have been developed and is reported as a kind of "gold standard" at least for 
the embolization of CDAVF.  
Cognard et al (257) reported a prospective series of 30 patients treated with 
Onyx with an anatomic cure of 80% achieved and 6.6% complication rate 
(rebleeding and cranial nerve palsy)  
Xian Li et al (255) reported a 61.3% complete anatomic cure with clinical 
complication rate of nearly 20% in a series of 31 patients treated by Onyx.  
In 2009 several more small series including 5 to 30 patients have been 
published with complete occlusion rates ranging from 72% to 96% and 
clinical complication rates from zero to 10% (264-266) 
Wang et al published on five cases of an unusual complication with 
symptomatic Onyx migration to the heart and downstream to the draining 
vein of the lesions, questioning the consideration that Onyx is a controllable 
material.(267)  
In early 2010 several more publications appeared with complete anatomic 
cures ranging from 62.5% to 92% and clinical complication rate from zero up 
to 8% (268-272) 
Guedin et al presented a series of 42 consecutive CDAVF cases with CVD 
treated by transarterial embolization with NBCA achieving a complete 
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occlusion rate of 81% and zero morbidity and mortality, aiming to emphasize 
the importance of transarterial embolization using acrylic glue in the 
therapeutic management of such lesions, and to compare the results the 
authors obtained using this treatment with those reported in the literature for 
Onyx treatment of the same type of dural shunts. (273) 
Our skeptical attitude towards Onyx is based mainly on the achieved good 
results with low complications rate and few sessions by using other embolic 
materials and especially NBCA. Additionally it correlates with our critisism 
toward a philosophy that seems to inspire the whole process of embolization 
with Onyx, a philosophy of non-selective attack not only of the lesion but 
rather all the adjacent vascular structures often in a surprisingly great extent 
in an attempt to include the lesion in the attacked area, often with an 
unacceptable rate and/or kind of complications (274) 
Often an indirect allusion is made that a high angiographic cure rate cannot 
be achieved without paying a price (anecdotal data), thereby overestimating 
the value of an imaging result against the actual clinical condition of each 
individual patient. 
As it was mentioned in the results, 27 patients with lesions presenting very 
tortuous feeders and diffuse supply or lesions with minimal supply from tiny 
and/or dangerous feeders, PVA was used as the only embolic material 
throughout their management. One of these patients manifested slight 
clinical (bruit) or imaging indications of recurrence but no further treatment 
was suggested. Fourteen other patients with initially obtained complete 
occlusion plus five more patients with initial incomplete occlusion remained 
without clinical symptoms and with MR imaging confirming the initial result. 
Seven patients with incomplete initial occlusion showed complete 
dissapearance of vascular abnormalities indicating presumably a progression 
to complete occlusion.  
9.8 Alternative treatment modalities 
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Gamma knife treatment (GKT) is considered an alternative treatment for 
CDAVFs. Major disadvantages of this therapy include the time elapsed 
before obliteration and the possibility that not all shunts will be obliterated. 
Actually the reported results after 24 months are showing complete occlusion 
rates between 50 and 75% (275-277) 
The vast majority of the benign lesions after observation or palliative 
treatment have a benign course(128) with extremely low risk. 
Therefore, a curative g-knife treatment for these lesions is unnecessary, 
because the (long-term) morbidity and mortality rates will most probably not 
outweigh the natural course of the disease.  
Lesions with CVD on the other hand have a contraindication for radiosurgery 
mainly because its result is not achievable in a timely fashion. Consequently, 
GKT can be theoretically used only in the treatment of benign CDAVFs with 
subjectively intolerable symptoms or aggressive CDAVFs not accessible or 
not responsive to endovascular treatment or surgery. 
In our series no case was refered for g-knife treatment because for none of 
our patients it was judged that further treatment with radiosurgery was 
necessary or in cases of incomplete occlusion that it would offer any 
additional benefit for the patient.(275-277) 
Surgery for the obliteration of DAVFs is frequently associated with higher 
risks,. (32, 278-281) 
Some groups have suggested selective surgical disconnection of the draining 
cortical vein as a minimally invasive and effective treatment for lesions with 
CVD. Actually, simple surgical disconnection of the cortical venous reflux 
maybe a good option in the management of patients with Borden type II or 
even type III superficially located dural arteriovenous fistulas when anatomic 
features prevent endovascular access, or embolization fails to obliterate the 
lesion. This procedure is a much smaller surgical undertaking and is 
associated with fewer complications than attempts to resect or pack the 
whole fistula, especially if located in the skull base. (282-286) 
For a minority of cases, a combination of treatments offers a better chance 
for success. Most of the lesions, however, require only one approach and 
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this is the endovascular approach. For some particular locations as for 
example, anterior fossa CDAVFs surgical obliteration alone is sometimes 
advisable when endovascular approach fails.  
10. CONCLUSION 
Endovascular embolization is the treatment of choice for the treatment of 
CDAVFs. High percentage of anatomical cure or subtotal-extensive occlusion 
of the lesion with even higher rates of excellent clinical results associated 
with very low operative complication rate can be achieved with few 
embolization sessions per patient.  In our view, these results can be reliably 
achieved through a philosophy of selective attack of the AV shunt and 
especially its venous component, mastering a certain permanent embolic 
material and avoiding both overtreatments and aggressive approaches based 
on overestimated imaging features and ignoring the actual clinical aspect of 
the disease. 
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11. TABLES 
 
 
Borden Classification   Cognard Classification 
Type 1: DVS/MV outflow only Type I: DVS/MV outflow only (anterograde) 
 Type IIA: DVS/MV outflow only (retrograde) 
Type 2: DVS/MV outflow &CVD Type IIB: DVS/MV outflow (anterograde) & CVD 
 Type IIA+B: DVS/MV outflow (retrograde)&CVD 
Type 3: CVD only Type III: CVD only (no ectasia) 
 Type IV: CVD only (ectasia) 
 Type V: CVD only (spinal) 
   
Table 1. Summary of classification schemes  
        
Abbreviations: AVF: arteriovenous fistula; DVS: dural venous sinus; MV: meningeal vein; 
CVD: cortical venous drainage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  55 
 
 
 
Borden No Patients Cognard No Patients 
Type 1 74 Type I 39 
  Type IIa 35 
Type 2 32 Type IIb 10 
  Type IIab 22 
Type 3 51 Type III 23 
  Type IV 22 
  Type V 6 
 
 
Table 2. Venous drainage according to Borden and Cognard classiffication 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  56 
 
 
 
CLASS BENIGN  VOA AGGRE
SSIVE 
VOA 
B1 71 7 Thr, 6 Ste, 5 Var, 3 Dil 2 1 Ste 
CI 36 1 Thr, 4 Ste, 2 Var, 1 Dil 1 1 Ste 
CIIa 35 6 Thr, 2 Ste, 3 Var, 2 Dil 1  
B2 21 5 Thr, 5 Ste, 1 Ste+Var 10 2 Thr, 2 Ste, 2 Var, 
1 V+S 
CIIb 4 2 Ste 5 1 Ste, 1 Var, 1 V+S 
CIIab 17 5 Thr, 3 Ste, 1 Ste+Var 5 2 Thr, 1 Ste, 1 Var 
B3 9 2 Thr, 1 Ste, 1 Var 41 4 Thr, 14 Var, 1 
V+T, 1 V+S 
CIII 8 2 Thr, 1 Ste 15 1 Thr, 1 Var, 1 V+T,  
1 V+S 
CIV 1 1 Var 20 3 Thr, 12 Var 
CV   6 1 Var 
VE 49 5 Thr, 2 Ste, 4 Var, 1 
Ste+ Var, 3 Dil 
3 1 Thr, 1 Ste 
DE 28 9 Thr, 4 Ste 17 5 Thr, 2 Ste, 3 Var, 
1 Ste+Var, 1 V+T 
LE 5 1 Var 31 12 Var, 1, 1 V+S 
VE+DE 16 1 Thr, 6 Ste 0  
DE+LE 3   2 1 Var 
 
 
Table 3. The clinical presentation in relation to classifications according to 
venous drainage and epidural space 
 
Abbreviations: CLASS=classification, C(I to V)=Cognard classification, B(1 to 3)=Borden 
classification, VOA=venous outlet abnormality, Thr=thrombosis, Ste=stenosis, Dil=dilatation, 
Var=varix 
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Post-op  Follow-up  No 
CAO Clinical & MR follow-up confirmed the known CAO. One pt 
died because of MM  
 
92 
pts 
CAO Clinically recurrent symptoms (1 bleeding)  DSA and 
embolization (3 Complete, 1 Subtotal) 
 
4 
pts 
CAO MR: persisting shunt-no CVD – Clinically: asympt    F-up  
 
5 
pts 
InAO MR: occluded shunt - Clinically: asymptomatic    F-up  
 
35 
pts 
InAO Clinical & MR follow-up confirmed the known InAO       (1 
pt  with persistent CVD  cerebral bleeding and death). 5 
pt with CVD. 
 
11 
pts 
InAO Lost to F-up 3 
pts 
CAO Recently treated 3 pts have no follow-up, (1 pt died 
brainstem bleeding).  
4 
pts 
 
Table 4. Follow-up  
 
Abbreviations: CAO: Complete angiographic occlusion, InAO: Incomplete angiographic 
occlusion 
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 Gender Mean 
Age 
CVD  VOA VOA  in 
CVD 
High 
Flow in 
CVD 
? 
VE 57% F 61.3 y 20% 32.5% 60% of 
CVD 
10% of 
CVD  
30% of 
CVD 
DE 58% M 53 y 49% 55.5% 61%   
of CVD 
4.5%  of 
CVD 
34.5% 
of CVD 
LE  73% M 54.4 y 100% 37%    
 
 
Table 5. Epidural space in relation to gender, age, CVD & VOA 
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SERIES  No of 
Pt 
M\F 
 
Age  
(mean/range) 
Single/ 
Multiple 
F‐u  Predispos
ing 
factors 
Presentation  Imaging  Location  Venous 
drainage 
Venous outlet 
alteration 
Management  Approach  Materials 
used 
No of  
Sessions 
Angiographic 
outcome 
Early 
Clinical 
outcome 
Operation 
Complications 
Follow‐up 
Outcome 
Changes 
V. Halbach et 
al 1987 
28  13\15  53y/28y‐72y  ‐  19m  ‐  H:8  
O:20 
‐  TS:28  ‐   SIT:18% ‐ 32% 
“abnormal” 
venous 
drainage 
C:5 
E:17 
 E+S:6 
TA:28 (?)  G:15   
P:3   
G+P:5 
‐  C:10 
InC:7  
(13 if Co with S 
is included) 
C:10 
 Im:6 
S:1  
(C:14 Im:8  
with Sx) 
P:2  ‐ 
V. Halbach et 
al 1987 
30  7\22  47y/22y‐75y  29/1  31m  P:4  OVH:77%   
CNP:50%   
DVA:27%   
O:47% 
‐  C:30  IIB:10% 
 
‐  Comp:8 
E:20 
Co:2 
TA:22(?)  G:11  
P:6  
G+P+?:5 
‐  C:18 
Im:4 
C:18 
 Im:4 
Tr:2  
P:1 
AC:1 
‐ 
Fermand et al 
1987 
43  15\28  53y/19y‐82y  1 bilat  40m  T:7  
IH:1  
TPh:1 
O:43   
IH:3 
3pt CT 
normal 
TS:41 JB:2  IIA:12 ‐ 
IIAB:4 
 
SIT:20  
SIS:2  11T/S? 
C:7 
E:34 
S:2 
Not 
mentioned 
(TA?) 
G:7   
P:19  
 D:27 
54  Not mentioned  C:13  Im:30  0  2 pt more 
no tinnitus 
(15) ‐ Im:9 ‐
S:9 ‐ W:1 
Debrun et al 
1988 
37   ‐   ‐   ‐      ‐  O  
CNP  
DVA 
‐  C:37  ‐  Partial 
thrombosis of 
C sinus in 28 
pts 
E:29 
S:1 
C:3 
TA all 37  G:11  
P:14   
G+P:10 
35  C:14  C:14 Im:15       
Urtasun et al 
1996 
24  9\15  58y/25y‐87y  24/0  C:10.
8m 
96%p
t 
A:12.
7m  
62%p
t 
   T:4   
   S:1  
M:2 
H:2   
I:1  
Nd:1   
S:1  
LVH:1   
IH:5  
O:19 
‐  TS:20  SS:4  I:13% ‐ 
IIA:29% ‐ 
IIB:29% ‐ 
IIAB:29% 
 
75%SIT 
25%SIS 33%AT 
E:22 
Co:2 
TV:5  
TAV:19, 
including 
2:O 
C:13  
G+C:11 
61 (32TA ‐
26TV ‐
3TAV) 
C: 71%  
S: 12%  
M:17% 
83%:C 13%:I  
4%:S 
Tr:8%  
P:8%  
D Un:4% 
4% angio C ‐ 
8% clinical 
W 
 
Bavinski et al 
1996 
30  11\19  54y/18y‐85y  ‐  48.3
m 
T:2   
I:4 
OVH+O:18  
H+S+Nd+IH:12 
‐   TS:14  C:10  
JB:1 
T:5 
IIAB/III: 30% 
 
13T 
1S 
6VD 
C:2  
E:20 
Co:8 
TA:26  
TAV:2 
G+P:2 
G+C:2 
G:4 
C+P:11 
  G+P+C:3  
C+D+F:5  
C+P+F:1 
 
57 (54TA ‐ 
3TAV) 
C:6 
 InC:22 
C:10 Im:11 
 S:3  
W:3 
D:1? 
P:7%  
P Un?:3% 
5 spont 
angio C ‐ 4 C 
after Sx/Rx 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SERIES  No of 
Pt 
M\F  Age  
(mean/range) 
Single/ 
Multiple 
F‐u  Predispos
ing 
factors 
Presentation  Imaging  Location  Venous 
drainage 
Venous outlet 
alteration 
Management  Approach  Materials 
used 
No of  
Sessions 
Angiographic 
outcome 
Early 
Clinical 
outcome 
Operation 
Complications 
Follow‐up 
Outcome 
Changes 
Olteanu‐
Nerde et al 
1997 
30  17\13  52y/17y‐82y  ‐  6m‐
24m 
S:1  
AVM:1 
H:5  
Nd:5  
S:1 
DVA:1 
IH:4 
O:30 
‐  TS all 30  I:60% 
IIA:16.% 
IIB:16.% 
IIab:3.5% 
III:3.5% 
20% venous 
stenosis or 
occlusion 
E:22 
E+S:8  
TA:21  TV:1   P:13   
G:9  
P+G:6 Bal:1 
 Co:1 
59  C:10(45.5%) 
InC:12(54.5%) or       
C:33.3 ‐ 
InC:66.6% 
C:10+8 
Im:11  
S:1 
Tr:2(6.6%) 
P:1(3.3%)  
they state 
3/59(5%) 
‐ 
Dawson et al 
1998 
24  9\15  54y/40y‐80y   ‐  30m  T:2 
remote 
H:1 
Nd:2 
CNP:1 
O:31 
‐   TS all 24  I:29% IIa 
&b:50% 
IIab:16.5%, 
III: 4.5% 
‐  E:22  
E+S:2? 
TA:9   
TV:8  TAV:7 
... and 
ethanol 
‐     C:21 (1 with 
Sx) Im:2 
S:1 
P:2    
Shah et al 
1999 
41  11\30  1y‐79y   ‐     ‐  H:3 
CNI:6 
O:41 
11CT 
inaccurat
e/10MR 
showed 
abnormal
ities 
TS all 41  I:12% ‐  
II:49% ‐ 
III:29% ‐ 
IV:10% 
‐  Comp:3  
E:25 
(2 of them  
+comp) E+S:13 
TA:36 TV:16  G:7 
P:25  
C:22 
Eth:8 
52  C:14(37%) 
InC:28(63%)? 
C:34(83%) 
all 
modalities 
P:6(14.6%) all 
modalities 
Angio 
C:17(41.4%) 
all 
modalities 
Friedman et 
al 2001 
23  5\18  57y/33y‐79y  ‐  21m 
for 
17pts 
‐  H:2 
CNI:2 
O:22 
‐  TS all 23  I:52% ‐ 
IIA:30% ‐ 
III:17% 
 
SIT:7 
SIS:2 
E+R:20(87%) R:3  TA all 20  Mainly P 
(few+ 
gelfoam & 
silk) 
‐  ‐  C:20(87%) 
Im:2(9%)  
S:1(4.5%) 
Tr:1(5%)  
+ Tr1 & P:1 in 
angios 
In 21m for 
17p angio/ 
C:7(41%) ‐ 
S:4(24%) ‐ 
M:6(35%) 
Kim et al 
2002 
53  20\3  45y/1m‐71y  50/3    25.5
m 
T:5  
S:1  
C:2  
I:1  
P:1 
A:2  
H:6 ‐ Nd:4 
 S:2 –  
OVH:27 –  
DVA:10 –  
CNP:12 –  
IH:28 –  
O:3 
‐  TS:12  C:34 
JB:1 
 SS:3 
T:1 
FM:2 
I+IIA:62% ‐ 
:38% 
 
58.5% T of S 
and/or V 
C:13 
E:38  
S:1 
Co:1 
TA:28  TV:7  
TAV:4 
 ‐  71 (58TA ‐
9TV ‐4TAV) 
C:33.3% 
InC:66.6% 
C:33.3% 
Im:30.7% 
SW:25.6% 
L:10.2% 
Tr:%  
P:3.9%  
AC:10% 
‐ 
Meyers et al 
2002 
135  36\99  60y/18y‐87y   ‐  56m  P:6  H:2 
OVH:125  
DVA:46  
CNP:92 
O:66 
‐  C all 135  IIAB:30% 
 
‐  C:1 
E:133 
TV:101  
TA:32? 
C:87% 
Silk:13% 
G:3% data 
for TV appr. 
only 
179  C:121  
InC:14 
C:121 over 
a 5.4m 
mean 
period 
AC:0.7%  P:0.7% 
O:5% 
72 f‐u DSA ‐ 
11 dead un. 
‐ 28 lost 
after mean 
20m 
  61 
SERIES  No of 
Pt 
M\F  Age  
(mean/range) 
Single/ 
Multiple 
F‐u  Predispos
ing 
factors 
Presentation  Imaging  Location  Venous 
drainage 
Venous outlet 
alteration 
Management  Approach  Materials 
used 
No of  
Sessions 
Angiographic 
outcome 
Early 
Clinical 
outcome 
Operation 
Complications 
Follow‐up 
Outcome 
Changes 
Tomak et al 
2002 
22  16\6  50y/35y‐80y   ‐        H:60%   
Nd:18.5%  
S:4.5% 
O:18% 
‐  T all 22  III:100% 
 
14% sinus 
thrombosis, 
77% venous 
varices 
E:45% E+S:55%  TA:18  TV:4  
TAV:1 
‐  ‐  ‐  Exc:77% 
Good:9% 
Fair:5% 
D:9% 
     
Chung et al 
2002 
60  22\38  53y/4y‐75y   ‐  14m  T:4  
 S:1  
STh:8  
Pinf:1  
Ac:3 
A:2 
H:13 
I:1 
Nd:2 
OVH:48   
CNP:49 
 DVA:1 
O:15 
30pt 
CT:70% 
abnormal 
36pt MRI: 
81% 
abnormal  
TS:12 
C: 34  
JB:2 
T:3 
AF:4  
Con:3 
 Torc:1  
Petrous 
surface:1 
I:38% ‐ 
IIA:5% ‐ 
IIB:5% ‐ 
IIAB:13% ‐ 
III:20% ‐ 
IV:18% 
 
‐  C:13 
E:33  
S:5  
R:5  
Co:2 
TA:17  
TV:11  
TAV:5 
‐  62     C:19 Im:22  
S:10 
W:7 
D:2 
Tr:2    
Cheng et al 
2003 
27  3\24  29y‐79y  12 bilateral  26m  ‐  OVH:26   
DVA:7 
CNP:5 
O:3 
 ‐  C all 27  I:48% ‐ 
IIA:4% ‐ 
IIB:48% 
SIT:9 bilat  
SIT:3 unilat 
E:27  TV:26 TAV:1  C:all  ‐  C:10 
InC:21 
C:26  
in 1‐4m 
Tr:2  14 more pts 
angio 
cure=24 pts 
Klisch et al 
2003 
25  8\17  57y  ‐  30m  ‐  OVH:8 
 DVA:6  
CNP:17 
O:9 
‐  TS:14 C:11   I:48% ‐ 
IIA:8% ‐ 
IIB:4% ‐ 
IIAB:32% ‐ 
III:8%  
‐     TA:15 TV:27  
(6 with 
Stent assist) 
‐  ‐     C:19 
 Im:6 
Tr:4 
AC:3 
O:3 
  
Kim et al 
2006 
56  11\45  57y/30y‐73y   ‐  13m   ‐  OVH:30   
CNP:26   
DVA:7 
O:31 
 
‐  C all 56  ‐  ‐  E all 56  TV:50   
TA: 
11+6(?) 
‐  ‐  C:52% 
 S:23% M+S:25% 
   Total:11 
(19.6%) 
Tr:9  
P:2 
C+Im:42(91
%) ‐ S:2 ‐ 
Recur:2 
Kirsch et al 
2006 
141  29\112  67y/23y‐85y  ‐  52m 
(for 
69pts
) 
‐  OVH:94%   
CNP:54%   
DVA:28%  
 O:19% 
‐  C all 141  IIA:88% ‐ III 
or/and IIAB: 
34% 
 
‐  E all141  TA:32 
TV:161 
P:32  C:161  193  C:81%   
S:13%  
M:4%  
F:2% 
C:30% 
Im:57% 
S:10% 
W:3% 
Tr:2  
AC:9  
O:2 
55% of pts: 
C:94.5% ‐ 
Im:5.5% 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SERIES  No of 
Pt 
M\F  Age  
(mean/range) 
Single/ 
Multiple 
F‐u  Predispos
ing 
factors 
Presentation  Imaging  Location  Venous 
drainage 
Venous outlet 
alteration 
Management  Approach  Materials 
used 
No of  
Sessions 
Angiographic 
outcome 
Early 
Clinical 
outcome 
Operation 
Complications 
Follow‐up 
Outcome 
Changes 
van Rooij et al 
2007 
29  24\5  54y/24y‐77y   ‐      ‐  A:4(14%)   
H:18(62%)   
S:4(14%)  
Visual:2(7%)  
O:1(3%) 
CT/ICH:16
pt ‐ 
SAH:2pt 
MRI/Dilat
ed veins: 
4pt 
‐  IIAB and/or 
III 100% 
 
Sinus 
occlusion: 
4(13.8%) 
E:14(48%) 
E+S:7(24%) 
S:5(17%) 
R:1(3.4%) 
plus 2 spont 
cure post H and 
I 
 ‐  G+C  ‐  C:14(66.6%) 
In:7(33.3%) 
(these 7 C if 
Surgery is 
included) 
‐  P:1(4.7%)  ‐ 
Xianli Lv et al 
2008 
31  21\10  43y/23y‐60y   ‐  7.8m  ‐  H:12 
Nd:1   
OVH:9 
O:13 
‐     I:10% ‐ 
IIA:35% ‐ 
III:10% ‐ 
IV:45% 
VS+VD in 
51.6% (III & 
IV) 
E all 31  TA:31 TV:1  O  ‐  C:61.3% 
InC:28.7% 
   TR:2  
P:2 
At F‐u GOS 
5:90.3%, 
GOS 4:9.7% 
Xianli Lv et al 
2008 
23  14\9  49y/11y‐70y  ‐  22.1
m 
‐  H:1 
Nd:1 
S:1 
OVH:14  
CNP:8 
O:14 
‐  TS:3  
C:17  
T:1 
AF:2 
IIA:74% ‐ 
IIAB:4.5% ‐ 
III:17% ‐ 
IV:4.5% 
‐  E:23  TA:6  TV:28  C:24  
O:4  C+O:6 
34  C:21 
InC:2 
C:12  
Im:5  
S:5 
W:1 
Tr:2  8 f‐u angio:1 
recanal ‐ Cl 
f‐u C:21 ‐ 
S:1 ‐ W:1 
Cognard et al 
2008 
30  18\12  62.4y/36y‐76y  ‐  3m  TPh:5 T:3  A:2  
H:16  
I:2  
Nd:1 
S:4  
DVA:1 
IH:1 
O:1 
‐   TS:15 SS:4  
T:5 
FM:1  
AF:2  
VG:1  
FC:1 SphS:1 
IIB:20% ‐ 
IIAB:13% ‐ 
III:27% ‐ 
IV:40% 
 
SIT:10  E:26 
E+S:2 
E+R:2  
TA all 30  O   at least 35  C:24 
InC:6 
‐  P:2  F‐u in 23 pts 
comfirmed 
results 
Xianli Lv et al 
2009 
21  14\7  46y   ‐  28m  ‐  H:3 
Nd:5 
OVH:7 
 DVA:6  
O:12 
‐  TS:7  
C:6 
T:4 
AF:2  
Torc:1  
Cerebellar 
convex:1 
‐  ‐  E all 21  TA:21 TV:1  O:15  
 O+C:6 
‐  C:14 
InC:7 
‐  Tr:5  
P:1 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SERIES  No of 
Pt 
M\F  Age  
(mean/range) 
Single/ 
Multiple 
F‐u  Predispos
ing 
factors 
Presentation  Imaging  Location  Venous 
drainage 
Venous outlet 
alteration 
Management  Approach  Materials 
used 
No of  
Sessions 
Angiographic 
outcome 
Early 
Clinical 
outcome 
Operation 
Complications 
Follow‐up 
Outcome 
Changes 
Cohen et al 
2009 
42  19\23  62y   ‐  26.3
m 
‐  “Neuro”:35%  
Other:56% 
OVH:37% 
13pt CT:2 
abnormal 
‐ 26pt 
MRI:13 
abnormal 
TS:56.5% 
Petrous 
ridge:39% 
Both:4.5% 
I:19.5% ‐ 
IIA:21.8% ‐ 
IIB:17.4% ‐ 
IIAB:24% ‐ 
III:4.3% ‐ 
IV:15% 
‐  C:2.2% E:71.7% 
S:6.5% 
E+S:19.5% 
‐  ‐  ‐  C:90%(?)  ?  Tr:2  
P:1 
AC:6 
‐ 
Agid et al 
2009 
24  22\2  57y/3y‐77y  22/2   15.8
m 
‐  A:25%  H:46%  
Nd;8% 
S:8%  
O:13% 
17pt 
CTorMR: 
H:10 ‐ E:4 
‐ Venous 
dilat:16 
AF all 24  III:100% in 
46% venous 
pouch 
‐  E:11 
S:11 
R:2 
‐  ‐  ‐     Embo: 
C:7/11  
None embo    
Xianli Lv et al 
2009 
40  29\22  43y/23y‐60y   ‐  8m  ‐  H:16  
OVH:11 CNP:2 
O:24 
‐  ‐  I:7.5% ‐ 
IIA:32.5% ‐ 
III:7.5% ‐ 
IV:45% ‐ 
V:2.5% 
 
‐  E all 40  TA:40 TV:1  O all 40     C:25(62.5%) 
InC:15 
   Total:9(22.5%) 
Tr:4 
P:5  
State:7.5 P but it 
appears:10‐
12.5% 
  
Kirsch et al 
2009 
150  71\79  58y/18y‐82  9 bilat  13m  ‐  H:15, I:3  
Nd:1, IH:6 
DVA:11 
S:5, O:150 
“org brain 
dysfunction”:3 
‐  TS all 150  I:31% ‐ 
IIA:29% ‐ 
IIB:20% ‐ 
III:17% ‐ 
IV:3% 
 
SIT:79  
AT:1 
E all 150  TA:33 TV:21 
TAV:96 
G:34 
 P:64 
 C:21 
G+P:16 
G+P+C:5 
P+C:8 G+C:1 
S:11 
50pts:1 
session 
 
 mean: 2.4 
C:79(52%) 
InC:71 
C:110 
(73%)  
Im:23  
S:13 
W:3 
Total:13(9%) 
Tr:10 
P:3 
46% of pts 
clin F‐u in 
13m (m):6 
more C &1 
Im. Angio F‐
u 44% of 
pts: 33 InC 
turned to C ‐ 
2 C 
recurrent  
Table 6 
FOLLOW-UP: C: Clinical, A: Angiographic 
PREDISPOSING FACTORS: T: Trauma, S: Surgery, M: Medications, C: Congenital, I: Infection, P: Pregnancy, IH: Intracr.Hypertension, TPh: Thrombophlebitis, STh: Sinus Thrombosis, PInf: Previous infarction, Ac: Acupuncture 
PRESENTATION: A: Asymptomatic, H: Hemorrhage, I: Infarction, Nd: Neurodeficit non bleeding/infarction, S: Seizures, OVH: Orbital Venous Hypertension, DVA: Decreased Visual Acuity, CNP: Cranial Nerve Palsy, IH: Intracranial Hypertension, Other: Tinnitus, headache etc 
IMAGING: N: Normal, E: Edema, I: Infarction, H: Hemorrhage 
LOCATION: TS: Transverse Sigmoid sinus, C: Cavernous plexus, JB: Jugular bulb, SS: Sup Sagittal sinus, T: Tentorium, FM: Foramen Magnum , AF: Anterior Fossa, Con: Convexity, VG: Vein of Galen, FC: Falx Cerebri, SphS: Sphenoparietal Sinus 
VENOUS DRAINAGE: AS: Antegrade Sinus, RS: Retrograde Sinus, RC: Retrograde Cortical, RSC: Retrograde Sinus and Cortical, C: Cortical only, CC: Cortical Congestion, S: Spinal 
VENOUS OUTLET ALTERATION: SIT: Thrombosis inv. Sinus, SIS: Stenosis of inv. Sinus, AT: Thrombosis of another S, AS: Stenosis of another S, VT: Draining vein thrombosis, VS: Draining vein stenosis, VD: Draining vein dilatation 
MANAGEMENT: C: Conservative, E: Endovascular, S: Surgery, R: Radiosurgery, Co: Combination 
APPROACH: TA: Intrarterial, TV: Intravenous, TAV: Combined, O: Other (percutaneous, Burr hole etc) 
MATERIALS: G: Glue, C: Coils, P: PVA, O: Onyx, D: Dura, F: Fibrin, S: Stent, Eth: Ethanol, Co: some combination 
ANGIOGRAPHIC OUTCOME: C: Complete occlusion, S: Significant occlusion, M: Moderate occlusion, Sl: Slight occlusion, F: Failure, InC: in the range of S, M, Sl 
EARLY CLINICAL OUTCOME: C: Cure, Im: Improvement, S: Same, W: Worse, D: Death, L: Lost to f-u 
OPERATIVE COMPLICATIONS: Tr: Transient Neurologic Morb, P: Permanent Neurologic Morb, D: Death, Un: Unrelated, AC: Asymptomatic complication, O: Other non Neurologic
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Christian Doppler Medical Center, Salzburg and 
Fellowship in Endovascular Neurosurgery - Interventional 
Neuroradiology. Neurosurgical Department, Christian 
Doppler Medical Center, Salzburg, Austria 
Sept 2000-Nov 01  Affiliation in Neurosurgical Dept of Euroclinic of Athens 
as Specialized Neurosurgeon  
Dec 2001–Dec 09  Chief of Neuro-endovascular Dept at Interbalkan 
European Medical Center, Thessaloniki, Greece 
Jan 2009–Present  Oberarzt at Dept of Neuroradiology, University of Zurich, 
Switzerland  
 
